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Summary 
 
The surgical management of chronic otitis media is ever evolving. This is also the 
case at the Chris Hani Baragwanath Academic Hospital where in recent times, 
certain new techniques were adopted and other older ones revisited. This changed 
surgical approach was deemed to be necessary not only in view of the limited 
resources available to deal with a large patient load, but also to improve surgical 
outcomes in the local environment. The focus was mainly on the implementation of 
internationally accepted surgical techniques that have been shown to not only be 
effective and safe, but also simple and time-saving. Changes were mostly seen in the 
management of patients presenting with simple perforations and cholesteatoma.                  
It is the objective of this study to formally assess the outcome and feasibility of this 
changed surgical approach, as well as to assess the outcomes of surgery as a whole. 
 
A retrospective clinical chart review was undertaken over an eighteen-month period 
from July 2009 to December 2010. All patients undergoing single stage surgery for 
chronic otitis media in this period were included, and grouped in terms of procedure 
performed, viz. Tympanoplasty, Tympanomastoidectomy and Canal wall down 
CWD mastoidectomy. All data were collected from an otological database, each 
case independently evaluated in terms of surgical and audiological outcomes after at 
least a 2 month follow up period. Only data acquired at the latest follow-up date 
were used. The follow up period ranged from 2 to 18 months. 
 
The Butterfly Cartilage Inlay Graft (BCIG) tympanoplasty technique was the 
predominant technique used for simple perforations of any size and location, and 
showed superior surgical outcomes to the more traditional Fascia underlay graft 
(FUG) technique. Surgical success (i.e. healed / intact tympanic membrane) in the 
FUG tympanoplasty group was 75%, compared to 93% in the BCIG group. One 
hundred percent of cases subjected to BCIG tympanoplasty achieved sociable 
hearing (ACT< 30dB) in the early post-operative period. We found the hearing 
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improvement post-surgery to be directly related to the size of perforation                             
(p= 0, 0195), and pre-operative hearing loss (p= 0, 0001 r= 0.93). None of the other 
variables studied influenced the audiological outcome achieved. 
 
In the study period, surgical techniques used for more severe Non-
cholesteatomatous chronic otitis media (NCCOM) were little changed from before. 
An evaluation of these cases focused on those with actively discharging ears to 
assess the outcome of Tympanomastoidectomy to achieve not only a dry ear, but 
also an intact tympanic membrane (TM) and hearing improvement (HI). Eighty-six 
percent of patients with discharging ears had dry ears post-operatively, 50% of 
which achieved an intact tympanic membrane and sociable hearing (ACT< 30dB). 
Graft failures in the tympanomastoidectomy group as a whole were mostly related to 
size of perforation (p= 0,047) and to the presence of discharge pre-operatively (p= 
0,012).  
 
In the CWD mastoidectomy group, although evaluating both the large (completely 
exenterated mastoid)- and small cavity techniques, the focus was on the latter. With 
this technique, disease is surgically approached from its site of origin, and followed 
into the attic and mastoid. The resultant defect in the medial canal wall and mastoid 
is kept as small as possible, to avoid obliteration and the morbidity of an 
unnecessarily large cavity. Dry ears were achieved in 93% of patients. In cases 
where the TM was grafted, an intact tympanic membrane was achieved in 85% of 
patients. Significant hearing improvement (>10dB in two consecutive frequencies) 
was achieved in 33% of patients who had the tympanic membrane grafted to an 
intact stapes suprastructure (Type 3 tympanoplasty with or without a cartilage 
columella). These results compared favourably to the large cavity CWD technique 
in this series where obliteration and middle ear grafting were not performed on a 
regular basis. In this group, only 16% of patients had an intact tympanic membrane 
post-operatively, and 63% of ears were dry at latest follow up. Although statistical 
analysis did not show one technique to be superior to the other in achieving a dry ear 
post-operatively (p= 0,39), the results with the small cavity technique were very 
encouraging. Hearing improvement in both groups were variable and hearing 
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preservation rather than augmentation was achieved in most. The lack of hearing 
improvement may not only have been related to the extensive disease encountered 
(80% extending beyond attic, 50 % stapes suprastructure erosion), but also to 
inadequate and infrequent reconstruction of the middle ear. 
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1.  INTRODUCTION 
 
Perforation of the tympanic membrane, with or without a chronic aural discharge 
is a common presenting problem at Ear, Nose and Throat (ENT) clinics in 
Johannesburg’s public hospitals. In the developing world, in addition to it being a 
leading cause of progressive hearing impairment, it is also associated with 
considerable potential morbidity. Surgery plays an important role to reverse the 
chronic infectious process in the middle ear and mastoid, and to rehabilitate 
hearing. 
 
The literature frequently classifies the chronic infectious disease processes in the 
middle ear and/or mastoid into Non-Cholesteatomatous Chronic Otitis Media 
(NCCOM) and Cholesteatomatous Chronic Otitis Media (CCOM). NCCOM 
refers to the presence of a perforated tympanic membrane, with or without a 
discharge, in the absence of keratin in the middle ear and mastoid. CCOM refers 
to the situation where keratinizing squamous epithelium has migrated to or 
appeared in the middle ear, mastoid and/or other parts of the temporal bone. 
 
Management of these two clinical entities is constantly evolving and is frequently 
tailored to the capabilities of an institution and to the patients’ expectations. In 
this respect, not only does the availability of resources and surgical expertise play 
a critical role, but also the patients’ reliability to follow up. 
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2. STUDY OBJECTIVES 
 
The aim of this study was to assess the outcomes of surgery for both NCCOM and 
CCOM at the Chris Hani Baragwanath Academic Hospital. 
 
It specifically aimed to assess the following: 
• Surgical and audiological outcomes of the BCIG tympanoplasty compared 
to the traditional FUG tympanoplasty. 
• Effectiveness of Tympanomastoidectomy in severe CCOM to:  
 Eliminate a discharge (if present),  
 Achieve an intact TM post-operatively, and 
 Improve hearing. 
• Effectiveness of the small cavity CWD mastoidectomy in achieving the 
goals of cholesteatoma surgery (see literature review). 
• The effect that certain variables may have on the outcomes of the above-
 mentioned procedures (see Methodology section). 
 
It is hoped that the outcomes of this study will further guide the management of 
these prevalent and important conditions to ensure an optimal outcome for 
patients. 
 
 
 
 
 
 
 
 
 
 
 
 3 
 
3. A REVIEW OF THE LITERATURE ON THE 
MANAGEMENT OF CHRONIC OTITIS MEDIA 
 
In this chapter, COM is discussed in terms of the pathogenesis and management 
of the disease processes involved. The chapter will make a clear distinction 
between cholesteatomatous and non-cholesteatomatous disease and will focus on 
certain aspects of surgery performed for these processes that is relevant to this 
study and our institution. 
The review of the literature aimed to flow in a natural manner, starting with a 
general overview of the subject, progressing to the general surgical considerations 
and further onto the aims of surgery and the relevant techniques to achieve the 
objectives of surgery.  
  
3.1. NCCOM (NON-CHOLESTEATOMATOUS CHRONIC OTITIS 
MEDIA) 
3.1.1. Definition and pathogenesis 
Acute otitis media is a common occurrence in any population. It occurs in most 
instances when an episode of Eustachian tube dysfunction leads to acute infection 
in the middle ear. Ongoing Eustachian tube dysfunction or non-resolution of 
infectious process in the middle ear or mastoid may result in the acute episode of 
otitis media becoming chronic. This in turn will result in the tympanic membrane 
to lose its elasticity, atrophy and to perforate without healing. (1) 
 
A perforated tympanic membrane exposes the middle ear to possible colonization 
by organisms from the external ear canal, and frequently results in a recurrent or 
continuous discharge from the middle ear. (2) Although opinions vary regarding 
the definition of chronic otitis media, most consider middle ear disease to be 
chronic if present for longer than 6 weeks. (2) 
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3.1.2 Classification 
According to the status of the middle ear, NCCOM may be Active, Inactive or 
Healed. (3) 
Active disease, when associated with a frank discharge from the middle ear, is 
also frequently referred to as chronic suppurative otitis media (CSOM). (2) In cases 
where signs of infection of inflammation (wet middle ear, mucosal edema) are 
present, but without a clear discharge, some prefer the term quiescent chronic 
otitis media to describe the condition of the middle ear. (4, 5) 
 
Theoretically, many systemic and upper respiratory tract conditions may cause or 
contribute to a discharge from the middle ear. Some of which include the 
following: 
• Regional pathology (upper respiratory tract), of which acute or chronic 
air-borne allergies, chronic laryngo-pharyngeal reflux, post nasal space-
adenoidal hypertrophy and tumors are the most common conditions. 
• Systemic pathology (patient immunity), of which host immune 
suppression (HIV, poorly controlled Diabetes Mellitus, chronic anti-
inflammatory medications etc.) is most important. 
 
Although a direct relationship between the mentioned factors and chronic otitis 
media has not been established, (2) it is common practice to treat positive regional 
and/or systemic findings as part of a comprehensive management protocol. This is 
especially the case in the pediatric population where the Eustachian tube is 
anatomically and functionally immature in its development, and where systemic 
and local immunity (IgA and IgG) are not fully developed. In these cases, CSOM 
can easily become a prevalent problem when poor socio economic circumstances 
and overcrowding prevail as well. (2) 
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Inactive disease refers to a persistently perforated tympanic membrane, but with 
no discharge or evidence of bacterial infection or inflammation. This situation 
suggests the possibility that previous causes of COM have resolved, or did not 
contribute to the disease process. (3) 
 
Healed chronic otitis media refers to a tympanic membrane that has healed either 
with the formation of excessive amounts of fibrosis and calcifications, or by the 
formation of a thin dimetric tympanic membrane where the middle fibrous layer is 
absent. The patient in such cases may still have variable levels of conductive 
hearing loss and is vulnerable to the development of retraction pockets or re-
perforation. (3) 
 
3.1.3 Management 
The management of NCCOM includes both medical and surgical treatment: 
 
3.1.3.1  Medical management  
Medical management is usually implemented in active NCCOM to resolve the 
middle ear and/or mastoid focus of infection/inflammation. It entails both topical- 
and systemic treatment, which may include the following: 
• Intensive and repeated aural toilet (debridement), 
• Short term topical antibiotics (with or without steroids), and 
• Treatment of the mentioned factors that affect Eustachian tube function 
and patient immunity. 
 
It has been shown that the combination of aural toilet and topical antibiotics are 
more effective than either alone in achieving a dry middle ear, and that this 
combination is superior to systemic antibiotics alone. (2) Topical quinolones were 
shown to be superior to non-quinolone eardrops in the same study. If successful, 
medical management will result in a healthy middle ear that will facilitate 
reconstructive surgery of the tympanic membrane and/or ossicles. 
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The duration given for medical treatment to take effect varies and is dependent on 
certain disease- and patient specific factors. Long periods of treatment, although 
possibly effective, (6) are frequently avoided though, as evidence exists that 
ongoing middle ear disease may result in further damage to the middle ear 
structures and possibly the inner ear. (2) 
 
3.1.3.2 Surgical management 
a) General surgical considerations 
Certain aspects of the surgical management of NCCOM may influence the 
outcome achieved. In the literature, the most commonly disputed areas of 
discussion include the questions of timing of the procedure, the need for mastoid 
air cell exenteration (mastoidectomy), and the effect that certain disease specific 
variables may have on the outcome of surgery. 
i. Timing of the procedure 
It is the opinion of some that a “dry ear” for a period of at least one month (7) is 
required to have a reasonable degree of certainty that the infectious process in the 
middle ear and/or mastoid is under control. All however do not share this 
thinking, and some believe that good results with TM reconstruction alone is 
possible as long as the ear is dry at the time of surgery. (8)  
 
In the pediatric age group however, a dry ear, even for the mentioned period 
above, may not lead to a good long-term surgical outcome. The effect that 
recurrent ear infections or Eustachian tube dysfunction may have on tympanic 
membrane perforation repair, is frequently the subject of discussion in the 
literature. Some believe that the procedure should be delayed as long as possible 
to allow for innate immunity and Eustachian tube function to mature, while others 
believe that surgery should be performed as soon as possible. Proponents of the 
latter approach are of the opinion that a delayed tactic may risk worsening of the 
ossicular defect and that an early repair, irrespective of age, will result in good 
long term outcomes as long as upper respiratory tract conditions are under control 
at the time of surgery. (8) 
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ii. Role of mastoidectomy in the management of NCCOM 
In cases of an actively discharging ear (with granulation tissue and polypoid 
mucosa formation), it has been shown that mastoid exenteration frequently, but 
not always results in disease resolution. (6, 9) A number of patients however will 
need intensive aural toilet and topical antibiotics post-operatively to finally 
achieve the goal of a dry ear. Repeat operations may also be necessary to address 
residual perforations. (6) 
 
In the case of only minor changes in the middle ear mucosa (quiescent chronic 
otitis media) studies have shown that good outcomes are possible, irrespective of 
whether mastoidectomy was added to tympanoplasty or not. (4, 5, 8) It is believed in 
such cases, that the secretory diseased mucosa will normalize spontaneously once 
the tympanic membrane perforation has been repaired, and that any residual 
mucous will be of low viscosity that can easily be cleared into the nasopharynx 
via the Eustachian tube. (8)v  
 
More severe disease (as indicated by the presence of polypoid mucosa or 
granulation tissue) however may warrant the addition of a mastoidectomy, the 
reason for its consideration being twofold. Firstly, disease in the mastoid reflects 
that of the middle ear and a failure to address this mastoid extension of disease is 
likely to increase the risk of early failure. (5, 10) Secondly, mucosal damage in such 
cases may be of such an extent that its normalization post grafting is unlikely. 
Surgical excision of this permanently damaged, fibrotic mucosa from the mastoid 
may be indicated to prevent late graft failures or recurrent perforations after 
healing has occurred. (11)  
 
Evidence also exist however that the presence of granulation tissue in the middle 
ear and mastoid, in fact does not compromise graft survival. Studies have shown 
that tympanic membrane grafting without mastoidectomy in such ears, may result 
in similar success rates and that hearing improvements will be equivalent to cases 
where a mastoidectomy was added. (12, 13) 
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The surgery required for inactive NCCOM may also include a mastoidectomy in 
addition to the grafting of the tympanic membrane. (12) The theory is that 
fluctuating middle ear pressures can be buffered by the surgical creation of a 
mastoid “air reservoir”, and that long-term graft success rates are improved by 
doing so. (10) Many challenge this opinion though, stating that mastoidectomy has 
no advantage over grafting alone in such cases. (5, 14) Some in fact believe that the 
removal of non-diseased air cells, may negatively affect success rates in such ears. 
(12) Although clinical support for the latter theory is lacking, (15) it is plausible that 
a reduction in the true surface area of the mastoid may reduce its middle ear 
pressure buffering capacity, (10) and result in future atelectasis, retraction pockets 
and cholesteatoma formation. 
 
In view of the above, contrasting evidence exists regarding the approach to a 
failed tympanic membrane repair. In such cases, some have shown the benefit of 
adding a mastoidectomy, (10) while others have shown that a mastoidectomy may 
still be avoided as long as a more resilient grafting material is used. (16) In this 
respect, cartilage has been shown to be particularly useful, especially when 
Eustachian tube dysfunction is suspected, and recurrent ear infections are 
expected in future. 
 
iii. Effect that patient variables may have on the outcome of surgery 
The status of the contra-lateral ear may reflect Eustachian tube function and 
therefore may influence surgical outcomes. Studies however are contradictory on 
its role in the determination of success, as some have shown no correlation 
between this variable and success rates, (7,17,18) while others have shown it to be an 
independent variable determining outcomes in pediatric patients. (19) 
 
Age has been shown to negatively affect surgical success rates over the longer 
term (2-5 years) but only in younger children (< 6 y of age). (18) As mentioned, 
immunity problems and recurrent Eustachian tube dysfunction are the possible 
reasons given for failures in this age group. In adults, although graft success rates 
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have not been shown to be related to age, it is known that late audiometric 
outcomes are frequently worse than earlier recorded ones (8)  
 
Size of perforation may influence graft success rates based on graft instability 
and difficulties experienced in the repair of large or subtotal perforations. (20) The 
instability of certain grafting materials (i.e. fascia) may not allow for healing by 
secondary intention to occur in such large perforations (18) resulting in residual 
perforations or retraction pocket formation in the anterior segment of the 
tympanic membrane (21). Size of perforation may affect hearing outcome, as 
hearing improvement post repair, in most cases, will be directly proportional to 
the size of the perforation pre-operatively. (22) 
 
Before performing surgery, one assumes that the original insult responsible for the 
sequelae of perforation and the subsequent reasons for its persistence have been 
resolved. In many cases, this assumption will prove to be correct; but in some, 
persistence of causative factors may remain undetected and undefined with 
consequent late failure of the procedure. Follow-up period thus may play a role 
in reported outcomes as well. (23) 
 
Surgical technical issues may affect outcomes as well. Whereas such issues may 
not be a factor in the outcome of surgery for central or small perforation, (18, 22) it 
may play a significant role when dealing with subtotal- (20) or anteriorly located 
perforations. (7, 22) 
 
b) Theory behind surgical hearing rehabilitation 
For optimal conduction of sound from the tympanic membrane to the inner ear, 
the main requirements include the following (24): 
i. An intact tympanic membrane and ossicular chain  
Sound transmission from the tympanic membrane to the oval window requires an 
intact ossicular chain. Ossicular coupling is the sound pressure gain that occurs 
through the tympanic membrane and ossicular chain and is a factor of the 
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effective vibrating area of the tympanic membrane to the area of the stapes 
footplate. 
 
ii. Aeration of the middle ear cavity  
Air reduces the pressure difference between the external ear canal and the middle 
ear, allowing the tympanic membrane and ossicular chain to move.  In addition, it 
reduces the resistance to the flow of acoustic energy through the cochlear fluids 
from the stapes footplate to the round window membrane. At least 0.5ml of air in 
the middle ear is required to maintain hearing within 10 decibel (dB) of normal. 
 
iii. Normal stapes to cochlear impedance 
An impediment to the movement of the stapes or round window membrane, such 
as pathologic changes in the annular ligament of the stapes or fibrous tissue in the 
round window niche, may contribute to a conductive hearing loss. 
 
iv. Minimal acoustic coupling (Phase protection) 
Sound pressure that acts directly on the oval and round window simultaneously 
(e.g. ossicular interruption behind an intact tympanic membrane or a total absence 
of the tympanic membrane) will reduce the hearing gain through the middle ear. It 
is therefore imperative to channel most of the sound pressure directly to the oval 
window to have optimal sound transmission through the cochlea. 
 
In most cases of NCCOM, the perforated tympanic membrane is the main cause 
of the hearing loss, which when repaired, will improve the patient’s hearing. 
Closure of the tympanic membrane defect will have a maximum effect on hearing 
in the 500Hz-, 1000Hz- and 2000Hz frequencies, (25) which when averaged, can 
be expressed as the pure tone average (PTA) or air conduction threshold (ACT). 
 
Because hearing improvements in the higher frequencies (3000-4000Hz) is 
important for speech discrimination in noisy environments, either of these 
frequencies may be included in the PTA as well. (25) Controversy exists however, 
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as to whether its inclusion will materially affect the measured post-operative PTA, 
and many continue to only use a 3-frequency average to report results. (25) 
 
Because sociable hearing lies in the range of 20 to 40dB, surgery should aim to 
improve or maintain hearing in this range. Many would consider the surgical 
procedure successful, if the patient’s speech reception threshold can be improved 
to, or maintained at a level better than 30dB. (8) It has been shown in a large meta-
analysis that these hearing levels can be achieved in 88% of patients with simple 
tympanic membrane perforations. (18) 
 
In the absence of obvious ossicular discontinuity, many cases may still have sub 
optimal hearing improvement post successful perforation repair. It is important in 
such cases to consider other adverse conditions in the middle ear that may have 
been present or occurred after surgery. Conditions that may affect outcomes 
include middle ear space reduction secondary to fluid accumulation, granulation 
or fibrous tissue formation, and retraction of the tympanic membrane. Subtle or 
undiagnosed ossicular chain abnormalities may also be responsible for 
unexpected hearing deficits post surgery. It is important not only to manage these 
conditions if present in the middle ear, but also where possible, to prevent it from 
occurring post operatively. 
 
In the case of suspected ossicular pathology in addition to a perforated tympanic 
membrane, the reconstructive effort may include the repair of both the ossicular 
chain and the TM perforation in the same setting (non-staged ossiculoplasty), or 
the TM perforation can be repaired and the ossicular reconstruction deferred to a 
later stage (staged ossiculoplasty). The decision as to which approach to follow, 
is mostly made intra-operatively and is dependent on the extent of adverse middle 
ear conditions present in the middle ear. To prognosticate the outcome of surgery 
when such adverse conditions are present in the middle ear, a risk index can be 
used to determine the feasibility of non-staged surgery. One such risk index, the 
middle ear risk index (MERI), (26) includes the following variables: 
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• Extent of ossicular defect post disease clearance, 
• Status of tympanic membrane (perforated or intact), and 
• Presence of middle ear infection. 
 
Although this index may be helpful in determining whether a staged or non-staged 
approach is appropriate, these variables, alone or in combination, may not be as 
accurate a predictor of surgical outcome as was previously thought. (26) In 
addition, the impact that certain surgical and anatomical factors may have on the 
outcome of ossiculoplasty, are not included in this risk index system. The 
Ossiculoplasty outcome parameter-staging index (OOPS), may more accurately 
predict hearing outcome post ossiculoplasty in a variety of circumstances. (26) 
 
Even though a range of ossicular and anatomical defects may be present post 
disease clearance, the most common isolated ossicular defect remains the 
defective incus. (27) In such cases it has been shown that the ABG can be closed to 
within 20dB in more than 80% of cases, and that these hearing levels can be 
maintained over the longer term (2-5 years), irrespective of technique used or 
whether the surgery was staged or not.(27). Type of ossicular reconstruction 
prosthesis may also not affect outcomes in such cases when the suprastructure is 
present. The use of autologous (cartilage, ossicles)-, and allogenic (artificial 
prosthesis) grafts have all shown good results, even over the long term. (27)  
 
c) Tympanoplasty classification 
In order to simplify the description of the procedure performed to repair a 
defective middle ear sound conduction mechanism, many use the tympanoplasty 
classification system described first by Zollner and Wullstein. (28) This system, 
albeit very useful, is also very basic, and certain modifications have been added to 
more accurately describe the reconstructive procedure performed. A discussion 
and illustration (Figure 1) of the classically described procedures, as well as some 
of the modifications, will follow below. 
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Figure 1: Wullstein classification of tympanoplasties with modifications. (28) 
 
i. Type 1 tympanoplasty  
The procedure implies an intact ossicular chain and includes the surgical removal 
of middle ear pathology (e.g. granulation tissue), inspection of the ossicular chain 
and/or the lifting of a tympanomeatal flap to gain access to the middle ear. 
Although frequently used interchangeably with type 1 tympanoplasty, the 
procedure of repairing a tympanic membrane perforation without the lifting of a 
tympanomeatal flap or of the addressing of middle ear pathology, according to 
original descriptions, may also be termed myringoplasty. (20) 
 
 
 
 14 
 
ii. Type 2 tympanoplasty  
Type 2 tympanoplasty classically describes the procedure performed for a 
defective malleus, where grafting is to an intact mobile incus. Because the 
original description of the procedure implied that the “lever” mechanism of sound 
transmission to the inner ear is maintained, one may consider the repair of a 
defective incudo-stapedial joint as a type 2 tympanoplasty as well. (29) Such a 
repair may include the use of ionomeric cement, (29) allogenic prosthesis (30), or 
cartilage. (31) 
 
iii. Type 3 tympanoplasty (32) 
The original description of a type 3 tympanoplasty implies a defective incus with 
or without malleus erosion where grafting is to an intact mobile stapes 
suprastructure. If grafting is directly to an intact suprastructure, the terms 
tympano-stapediopexy (32) or simple (33) type 3 tympanoplasty may be used to 
describe the procedure. In many instances however, the procedure involves the 
placement of a columella (prosthesis) between the suprastructure and tympanic 
membrane/malleus or graft. By doing so, the middle ear cavity can be maintained 
and the hearing gain enhanced. Even in the absence of the “lever” mechanism of 
sound conduction, sociable hearing is still possible in the majority of intact 
suprastructure type 3 tympanoplasties. (1) 
 
With the expansion of ossiculoplasty techniques, a modification to the originally 
described procedure have come to the fore (see figure 1). According to such a 
modification, type 3 tympanoplasty is further classified in terms of the columella 
(prosthesis) used for reconstruction (see figure 1) and includes cases where the 
suprastructure is absent. (28) 
 
iv. Type 4 tympanoplasty 
Type 4 tympanoplasty describes the situation of an absent stapes suprastructure 
and the grafting of the tympanic membrane directly to the promontory, leaving 
the mobile stapes footplate exposed. The procedure, also termed “sonic shielding 
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of the round window membrane”, will eliminate the effect that phase cancellation 
might have on hearing. (34) Hearing gains, albeit limited, can be enhanced if 
cartilage is used to reinforce the aerated area over the round window membrane. 
(34)
 
 
v. Type 5 tympanoplasty  
This procedure classically describes tympanic membrane grafting to a newly 
created inner ear window in the lateral semicircular canal. (34) In the presence of a 
fixed stapes footplate, the procedure will allow for the propagation of sound 
waves to the inner ear. The grafting to an open vestibule (absent footplate) post 
disease clearance, also constitutes a type 5 tympanoplasty. (28) 
 
d) Type 1 tympanoplasty techniques 
As discussed, the surgical closure of tympanic membrane perforations has been 
the subject of intense debate since the first successful skin graft closure of a 
perforation in 1878. (20) Not only are the indications and contra- indications of this 
procedure controversial, but the many described techniques are adding to the 
difficulties of formulating a management plan for many such cases. 
 
Over time, many different tympanoplasty techniques have been developed to 
address the inadequacies or difficulties of previously described operations. 
Among others, the most frequently used ones include the STSG overlay- 
(Wullstein 1950), vein underlay- (Shea 1957), temporalis fascia underlay- (Storrs 
1961), “sandwich”- (Karlan 1979), swinging door- (Schwaber 1986) and 
“crowncork”- (Hartwein 1992) tympanoplasties. (20) 
 
Minimally invasive techniques also have a long history. First described in 1877, 
was the use of a paper patch for small perforations. More recently, the use of 
lobule fat grafts and self-stabilizing tympanic membrane patches have shown 
promise as minimally invasive procedures. (20) 
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The temporalis fascia graft used in an underlay fashion, is currently the most 
popular technique to repair the majority of tympanic membrane perforations. The 
graft is considered ideal for tympanic membrane grafting, as it is thin, durable, 
easy to harvest, abundant, and in the incision site used for exposure to the middle 
ear. Considering its mentioned drawbacks (see section 3.1.3.2 a iii) and the many 
(sometimes complex) grafting techniques developed to address these, (20) cartilage 
as grafting material has gained popularity.  
 
Previously, the use of cartilage grafts were limited to attic and posterior canal wall 
reconstructions. It is considered ideal in these circumstances, as its rigidity will 
prevent retraction pockets to form, especially in cases where middle ear aeration 
capabilities are questionable. (35) A gradual expansion of its use in middle ear 
surgery, and specifically tympanic membrane grafting, occurred however once 
perceptions regarding its negative impact on hearing was shown to be incorrect. 
(21, 35) The development of numerous cartilage-grafting techniques since, (36) has 
lead to its frequent use in revision surgery and large or peripherally located 
perforations. 
 
In 1998, its possible value as grafting material as part of a minimally invasive 
technique was realized when a novel grafting technique termed the cartilage 
butterfly technique was described. (37) The original technique, described for 
pediatric patients with small, easy accessible perforations, was used with 
perichondrium intact on both sides, in combination with a STSG. Subsequent 
expansions have lead to its use in larger perforations, (38-40) and as part of formal 
tympanoplasty techniques. (41) In adults, the technique gained favour as it could be 
performed under local anesthesia and on an outpatient basis (42). 
 
Other benefits of the BCIG technique include the following (42, 43): 
• Reduced theater time as compared to the fascia underlay technique, 
especially if performed under local anesthesia (LA). 
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• Reduced cost for the hospital (or patient), as the procedure can be 
performed as a day case procedure and post-operative analgesic 
requirements are minimal. 
• Enhanced post-operative patient comfort, as in most instances no external 
ear incisions are required. 
 
The technique entails the harvesting of a tragal- or conchal composite cartilage-
perichondrial graft as described, shaping it to the size and shape of the perforation 
and scoring its edge circumferentially between the two layers of perichondrium. 
(37) The graft is then “laid into” the fistularized perforation, the scored edges on 
either side of the tympanic membrane remnant (Figure 2). 
 
 
Figure 2: Illustration of cartilage preparation and placement with BCIG 
technique. (39) 
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The procedure may be technically difficult to perform if the entire perforation is 
not seen through the canal with the patient’s head and microscope in one position. 
Large perforations may thus be particularly troublesome to repair using a trans-
canal approach, and residual perforations may occur because of inadequate 
exposure. (39) In the pediatric age group, cartilage, and more specifically the BCIG 
technique, may be particularly useful as grafting material because of the increased 
possibility of recurrent Eustachian tube dysfunction. (38) 
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3.2 CCOM (CHRONIC CHOLESTEATOMATOUS OTITIS MEDIA) 
3.2.1 Pathogenesis and classification 
The migration of keratinized epithelium into the middle ear and the formation of 
cholesteatoma sacs remains and enigmatic pathological mechanism. Although 
various theories are forwarded to explain these processes, (44) a classification 
based on its site of origin is more practical, as not only does it improve the 
understanding of the disease process, but it also contributes a great deal to 
surgical decision making. 
 
Cholesteatoma can be classified into two groups according to the suspected 
pathogenesis viz. Congenital and Acquired. (45) 
 
3.2.1.1 Congenital Cholesteatoma 
Congenital Cholesteatoma is generally believed to originate from keratinizing 
epithelial deposits in the anterior tympanic cavity that occur during 
embryogenesis of the middle ear. By definition, there should be no history of 
middle ear infection or surgery and no perforation of the tympanic membrane. In 
advanced cases however, the distinction between congenital- and acquired 
cholesteatoma is not clear, as the one type may resemble the other. Up to a third 
of pediatric cases however may be of congenital origin. (45) 
 
3.2.1.2 Acquired Cholesteatoma 
Acquired Cholesteatoma is a disorder of the epithelial junction characterized by 
the medial displacement of the epithelial-mucosal boundary. (46) It can further be 
classified as being primarily- or secondarily acquired. (44) 
 
a) Primary Acquired Cholesteatoma (Attic cholesteatoma (47)) 
Eustachian tube dysfunction and the action that the resultant negative middle ear 
pressure has on the naturally weakened pars flacida (Shrapnel’s membrane) may 
be responsible for this type of cholesteatoma. (44) 
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The tympanic membrane retraction that forms because of the negative pressure in 
the middle ear, may progress into the attic and epitympanum, and cause epithelial 
debris and keratin to accumulate in the formed pocket. The cholesteatoma that has 
now formed, gradually expands, its growth accelerated by an intense 
inflammatory reaction that frequently ensues. (44) This type of cholesteatoma 
typically progress lateral to the ossicles (incus), and frequently results in medial 
canal wall (scutum) erosion. (48) 
 
Pediatric cases of cholesteatoma are often primary acquired. It may be that 
recurrent middle ear infections or OME predispose this age group to the formation 
of this type of cholesteatoma by not allowing for the development of the normal 
mastoid to middle ear air cell tracts (48) and/or by weakening the pars flacida. (44) 
The combination of a large mastoid antrum, deep air cell tracts, poor Eustachian 
tube function and an increased growth potential of tissues, frequently result in 
cholesteatoma to be larger and more extensive in the pediatric population. (46, 48) 
 
b) Secondarily Acquired Cholesteatoma 
In this type of cholesteatoma, epithelium gains access to the middle ear by a way 
other than via the pars flacida. The cholesteatoma may originate either through a 
marginal postero- superior perforation or retraction (sinus cholesteatoma), or may 
occur as a result of the entire tympanic membrane being retracted (pars tensa 
cholesteatoma). (49) The latter type may also form secondary to an epithelial 
invasion of the entire middle ear. Chronic inflammation and granulation tissue 
formation predisposes the middle ear for this process to occur. (46) Cholesteatoma 
normally propagates medial to the incus and malleus, over the stapedial niche and 
into the attic. (47) Scutum erosion is typically absent in these cases. 
 
Although the above classifications of cholesteatoma is helpful in the planning of 
surgery and reporting of outcomes, (47) frequently the distinction between the 
different types are not possible. This is particularly evident in advanced cases of 
cholesteatoma. (46) 
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3.2.2 Management 
Before sophisticated instruments and microscopes were available, performing 
destructive radical mastoidectomies were common practice in the management of 
cholesteatoma (and even NCCOM). (50) With the development of microscopic 
equipment and an improved understanding of the disease process, innovative 
surgical techniques developed with subsequent reductions in patient morbidity. (50) 
 
In general terms, in order to achieve an acceptable surgical outcome, certain goals 
have been described in the management of cholesteatoma. These can be 
summarized into the following (51): 
• Complete clearance of disease and the creation of anatomic conditions that 
 prevents recurrence. 
• Hearing preservation 
 
3.2.2.1 Clearance of disease 
The aim of disease clearance without considering disease recurrence is likely to 
lead to the ultimate failure of the procedure. Surgeons aiming to address both 
these aspects of surgery have to consider the options of disease clearance whilst 
preserving normal anatomy and clearance by sacrificing normal anatomy. In this 
respect, many follow either approach on an individualized basis, using certain 
cholesteatoma- and patient characteristics to decide on the appropriate course of 
action. (46, 47, 49) 
 
The two basic techniques to address disease include (48): 
• Canal wall up mastoidectomy (CWU) 
• Canal wall down mastoidectomy (CWD) 
 
a) CWU Mastoidectomy (52) 
With CWU mastoidectomy, the aim is to maintain normal anatomy as far as 
possible whilst still removing all cholesteatomatous disease. It involves a 
posterior tympanotomy and an extended facial recess approach, combined with a 
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thorough cortical mastoidectomy of all diseased air cells (healthy air cells are left 
in situ to facilitate mucosalization of the created cavity). Although the aim is to 
leave the external canal wall intact, often the medial canal wall is defective post 
disease clearance and then may require reinforcement with a rigid material such 
as cartilage to prevent recurrent retraction pocket and cholesteatoma formation. 
(46)
 
 
Although considerable controversy exists as to the indications for the procedure, 
arguably the technique is ideally suited for patients with limited attic (primary 
acquired) cholesteatoma. (46, 49) In pediatric cases presenting specifically with such 
cholesteatomas, the presence of a large aerated antrum may not only allow for the 
safe and complete removal of disease with reduced incidences of recurrence, (45) 
but CWU surgery will also avoid the morbidity associated with a large 
exenterated mastoid cavity. (46) 
 
In extensive pars tensa cholesteatoma (requiring mastoidectomy for removal (53)), 
the technique may be inadequate in achieving the goals of CWU surgery, mainly 
for the following reasons: 
• Considerable difficulty may be encountered in the complete removal of 
disease from the middle ear. Poor exposure offered by the technique in the 
facial recess  and sinus tympani may lead to residual macroscopic 
disease, which when  combined with the fact that even innocent looking 
mucosa may contain  microscopic squamous epithelium, (47) will lead to a 
high incidence of residual disease. 
• Significant mucosal sacrifice in the removal of the disease frequently 
results in a  mostly adhesive TM with very little if any hearing 
improvement post operatively. (46, 49) 
 
The problem of cholesteatoma recurrence is particularly troublesome with the 
CWU technique. Frequently the inherent inability of a cholesteatoma ear to 
maintain middle ear pressures and the negative pressure created in the large 
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mastoid cavity combine to cause such a recurrence. (51, 53) Young pediatric cases 
(<9 years of age) are particularly prone in this respect. (46) 
 
Although many recurrences with the CWU technique will occur in the first year 
post surgery, these may increase almost linearly over time. Recurrences can occur 
up to 10 years post-surgery and up to 60% of ears will have had a recurrence after 
this period. (53) Long term surveillance is therefore particularly important with this 
technique, and many will advocate routine second relook operations/procedures, 
either to exclude residual disease, or to manage recurrent retraction pockets and/or 
cholesteatoma formation. (54) In cases where cholesteatoma was confined to the 
attic and middle ear, and no mastoidectomy was needed in its removal, the 
suggestion is that pathologically significant recurrences will be evident on routine 
clinical examination, and that surveillance by way of close outpatient observation 
is appropriate. (49) Radiological surveillance may also be useful to avoid 
unnecessary second look procedures. (55) 
 
Presuming that most cases of cholesteatoma recurrence are secondary to factors 
other than the completeness of the surgical procedure itself, some authors believe 
that the single most important reason for the notoriously high recurrence rates 
may be poor surgical decision making. Their opinion is that recurrence rates 
below 10% are possible over the long term (10 years) in carefully selected 
patients. (49) 
 
Besides the problem of recurrence, other problems with the technique include the 
following: 
• Significant surgical skill and experience required in its safe performance. 
(52)
 
• Financial constraints and patients’ reluctance or inability to commit to a 
strict  follow up schedule and planned relook operations, may 
compromise the safety of the procedure. (46,51,54) 
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• Atrophy of the thinned posterior canal wall that may result in an irregular 
cavity that is inferior to a surgically created one. (53) 
• Hearing gains that can be less than expected and comparable to the CWD 
technique. (51,56) 
 
b) CWD Mastoidectomy 
In complicated cases of cholesteatoma (only hearing ear, septic intra- cranial 
complications, high anesthetic risk, facial nerve paralysis, sensori- neural 
hearing loss), and in cases where safe removal of the cholesteatoma matrix is not 
possible, CWD mastoidectomy is generally accepted by most to be the safest and 
most appropriate procedure. 
 
The reasons proposed for taking the canal wall down in uncomplicated cases 
include the following: 
• Disease clearance is simpler, as exposure in difficult to access areas in the 
middle ear and mastoid is increased. (51, 57) This is especially the case in the 
severely sclerotic and contracted mastoid with extensive middle ear 
disease. 
• Postoperative safety of the procedure is improved, especially in cases 
where  follow up may be troublesome. Possible disease recurrence is 
likely to progress externally rather than intracranially in such cases. (50) 
• Outpatient follow up is possible, most of the time negating the need for a 
planned relook procedure. This is a very important benefit where theatre 
time- and financial constraints prevail. Second look surgery however may 
still be necessary to exclude recurrences in the mastoid bowl after cavity 
obliteration or in the middle ear after tympanic membrane reconstruction. 
(58)
 These recurrences  however, assuming complete macroscopic 
clearance, are rare, even over the long term. (33, 51, 53 and 57) 
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In the literature two differing CWD techniques are commonly used, namely the 
large cavity- or “Fisch” technique, (33, 51, 53) and the small cavity- or inside out 
technique. (48, 50, 56-60) 
 
i. The “Fisch-“, or large cavity technique (51) 
This approach entails the complete exenteration of all mastoid air cells, and the 
removal of the cholesteatoma with or without mastoid tip amputation. Because the 
technique frequently results in the creation of sumps and/or crevices, obliteration 
is a necessary part of the procedure to minimize the collection of keratin debris 
and to reduce cavity size. A third important step of the procedure entails the 
placement of a graft to the middle ear. Although neo-tympanic membrane 
formation occurs in up to 50% of cases, grafting of the middle ear will increase 
the number of closed middle ears.  (59) It has been shown that a successful TM 
reconstruction will result in a dry cavity more often, as not only are the exposed 
middle ear mucosa and Eustachian tube separated from the mastoid bowl, but 
crevices in the middle ear are also eliminated, preventing the possible 
accumulation of keratin debris. (50) The performance of a meatoplasty that matches 
the size of the cavity completes the procedure. The aeration provided by a large 
meatus will further decrease the likelihood of a discharge in future. 
 
The disadvantages to this approach include the following: 
• Impaired sound dynamics and hearing outcomes secondary to the 
abnormal anatomy post-operatively. (33) 
• Problematic hearing aid (behind the ear hearing aid) fitting, because of a 
large meatus and absent external ear canal. 
• Undetected cholesteatoma recurrence secondary to an obliterated cavity. 
(53)
 Failed obliterations (recurrence, wet ear, and residual disease) may 
occur in up to  23% of cases. (59) 
• Significant morbidity because of a large meatus and cavity- patients may 
complain of intermittent discharge, vertigo, pain and cosmetic issues. (51, 
53)
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ii. The small cavity- or “inside-out” technique (56, 60) 
This technique involves the removal of cholesteatoma from the canal outwards to 
the mastoid. The aim is to match the size of the cavity to the size of the 
cholesteatoma to avoid the morbidity of an unnecessarily large cavity. 
Uninvolved, sclerotic bone is left in situ as far as possible. 
 
Small cholesteatoma involving the attic can be excised with the canal left intact 
and, depending on middle ear conditions, the middle ear is reconstructed to 
maintain near normal anatomy post operatively. (49, 57) Larger cholesteatoma 
involving the antrum can be removed and the cavity exteriorized. A cartilage–
perichondrial graft can be used to reduce the cavity size and prevent the formation 
of a retraction pocket into the remaining mastoid.  (56) 
 
Advanced cholesteatoma (deep into the mastoid) is managed by taking the canal 
wall down to the level of the facial nerve. This should be done as far distally as 
the floor of the external ear canal to expose the sumps and crevices in the 
supralabyrinthine area and mastoid tip. Focus in such cases should still be on 
retaining uninvolved mastoid bone as far as possible, but also to create a rounded 
smooth cavity by placing a graft to the middle ear and supralabyrinthine area 
where possible. (60) 
In most cases, obliteration of the cavity is not necessary, as it is likely to be small 
enough to avoid the morbidity associated with a large cavity. In fact, the cavity 
performed in this way may even resemble a normal, albeit widened external 
auditory canal post operatively. (50) 
 
The disadvantages of this approach include the following: 
• Surgical control may be suboptimal when drilling in a long narrow space. 
To enhance exposure, a canaloplasty (widening of the canal) at the 
beginning of the procedure is frequently required. (50) 
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• A continuous discharge post-operatively secondary to retained diseased 
mucosa and osteomyelitic bone. The reported incidence of dry ears post-
operatively however, appears to be similar between the small and large 
cavity mastoidectomy techniques. 
• Risk of Cholesterol Granuloma formation in sealed off retained mastoid 
air cells. Because the reported incidence of this phenomenon is low, it is 
possible that these air cells acquire ventilation somehow. A possible 
explanation is that air from the middle ear reaches the retained air cells via 
the retro facial air cell tracts. (56) 
 
3.2.2.2 Hearing rehabilitation  
Besides the avoidance of cavity problems, some CWU technique proponents have 
shown hearing outcomes to be superior to the CWD technique. (46, 49) Criticism to 
these results however relates to the fact that frequently the technique would not 
only be employed in cases with less severe disease, but also that these superior 
hearing gains frequently deteriorate over time to ultimately result in hearing 
outcomes equivalent to that of the CWD technique. (47) Long-term studies have 
shown that hearing outcomes are independent of technique, with only a third 
experiencing significant hearing improvement (>10dB). It further showed that 
hearing will remain unchanged in one third, and worsen in one third. (47) 
 
Because of these generally perceived poor outcomes, certain CWD 
mastoidectomy proponents consider hearing reconstruction in only a minority of 
their patients. (51) Some of the reasons given include the following: 
• Middle ear and mastoid aeration is poor in most cases of cholesteatoma 
(sclerotic mastoid and shallow middle ear cleft) and therefore do not allow 
for effective middle ear reconstruction. (56) 
• Large cavities may have adverse effects on the transmission of sound to 
the middle ear, and therefore may attenuate hearing gains achieved from 
an attempted reconstruction. (33) 
 
 28 
 
• Although considered significant to the surgeon, small hearing increments, 
especially in cases with uni-lateral disease, may be of no benefit to the 
patient. (51) 
 
Not all however agree that most patients with cholesteatoma will at best have 
limited and short lived hearing improvement post operatively. (57, 61-63) In order to 
achieve significant and meaningful hearing improvements however, it is 
necessary to take cognisance of, or address certain identified variables that may 
affect the outcome of surgery. These include the following: 
 
a) Status of stapes suprastructure 
Many have showed that grafting to an intact suprastructure results in better 
hearing outcomes than when it is absent. (45, 46, 57, 64 and 65) Although others have 
shown that this variable does not affect audiometric outcomes, (61) its presence in 
a well-aerated middle ear should encourage middle ear reconstruction, as hearing 
outcomes are likely to be good in such cases. 
 
b) Status of the contra-lateral ear 
Although the primary objective should be on the creation of a safe and care-free 
ear, in bilateral cholesteatomatous disease an attempt should be made to improve 
the hearing in the first operated ear. (46) In addition to the fact that patients with 
bilateral disease will appreciate any hearing improvement, even if limited, it may 
also be important to improve the worse hearing ear’s thresholds (ACT’s) to a 
level better than the better hearing ear’s. If successful, one can avoid the 
difficulties associated with operating on a better hearing ear in future, as the 
(initial) better ear will then be worse. 
 
c) The depth of the middle ear after surgery (amount of air in the middle 
ear) 
Granulation tissue in the middle ear, adhesive otitis media and adhesions post 
operatively, all contribute to a shallow cavity and poor hearing post-surgery. 
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Steps to deepen the middle ear cleft, such as the cartilage ring tympanoplasty (61) 
may improve outcomes. Similarly, the placement of silastic sheets or chromic 
catgut suture material in the middle ear may help to maintain this space by 
preventing adhesions to form. (50, 52) 
 
d) The size of the marsupialized cavity after the operation 
As discussed, the small cavity technique frequently results in a cavity resembling 
a widened external ear canal and therefore may limit the adverse acoustics effects 
of a large fully exenterated cavity. It has been shown that tympanoplasty in such 
ears frequently result in significant hearing improvements. (61) In case a hearing 
aid is needed for hearing augmentation, the small cavity may also lend itself to 
easier fitment and use of standard behind the ear hearing aids. 
With the large cavity technique, some authors may attempt to reconstruct the 
posterior canal wall (61) or to obliterate the mastoid cavity completely. (53) In doing 
so, not only does it facilitate ossicular reconstruction it also eliminates the 
acoustic effects of an open cavity. As mentioned though, the risk of undetected 
recurrence is increased. (53) 
 
3.2.3 Pediatric cholesteatoma and the small cavity technique 
Regardless of the fact that pediatric cases of cholesteatoma usually exhibit a more 
aggressive form of the disease, (45, 48, 53) some surgeons still place emphasis on 
initial functionality (normal anatomy and hearing improvement) rather than on the 
safety of a canal wall down procedure. (45, 46) The reasons mentioned is that in 
addition to allowing for normal speech and social development in this critical 
period to occur, the long term morbidity associated with a CWD procedure can be 
avoided. 
 
In experienced hands and in carefully selected patients, the CWU technique often 
results in good early surgical outcomes with more than 50% of cases achieving 
sociable hearing (ACT<30dB). (45, 49, 54) The difficulties associated with the CWU 
technique however, and the development of equally effective, more dynamic 
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CWD approaches are playing a role in some surgeons previously employing the 
CWU technique, to now favour the small cavity CWD technique. (60) This 
technique has shown promise in this population as near normal anatomy and 
hearing can be achieved with small cholesteatoma resections, while safety can be 
established in larger ones as the canal wall is taken down completely. (58) 
Providing middle ear conditions are favourable, surgery performed in this way 
may allow for the reconstruction of the medial canal wall if cholesteatoma is 
limited to the attic. (58) In such cases, the result will then be similar to that of the 
CWU technique, except for the possibility that recurrences will be less. The 
elimination of the negative pressure created by a large exenterated mastoid cavity 
is likely to prevent recurrent retraction pocket formation. (58) 
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4. OBSERVATIONS AND HYPOTHESIS 
 
4.1 OBSERVATIONS 
The motivation for this study came from some important observations made in the 
study period regarding changing trends in the surgical management of chronic 
otitis media. It allowed a hypothesis to be formulated according to anecdotal 
reports on the outcomes of surgery. This chapter will briefly discuss these 
observations and hypothesis. 
 
4.1.1. Surgical management of NCCOM 
In the past, FUG tympanoplasty was the preferred procedure at the CHBAH in the 
surgical management of simple dry perforations. Results were not formally 
studied but were deemed to be satisfactory at the time. The major problem with 
this technique though is that it is time consuming. Limited theatre time and patient 
load were major factors leading to the research of other less invasive techniques 
to manage simple dry tympanic membrane perforations. Literature reports on 
BCIG tympanoplasty have shown it to be a simple, quick and very effective 
technique. In cases of small simple perforations, the good initial results achieved 
with the technique, led to its use on an increasingly regular basis, and for more 
complex cases of NCCOM. 
 
4.1.2. Surgical management of CCOM 
It is the opinion of regional colleagues that CCOM managed in the local setting 
reflects that that is prevalent in the third world economic setting (generally 
advanced). This fact, as well as significant follow up issues and patient 
compliance problems has led many surgeons to opt for safety in surgical 
management rather than optimal functional outcomes. The retro auricular 
approach, with full mastoid air cell exenteration without obliteration or tympanic 
membrane reconstruction was previously the preferred approach in the surgical 
management of patients with cholesteatoma. In fear of undetected cholesteatoma 
recurrence, this approach was believed to be appropriate in most cases. 
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In the last few years, our surgical approach to cholesteatoma has changed. The 
literature evidence supporting the effectiveness of less radical procedures in 
cholesteatoma surgery, combined with perceived improvements in the socio-
economic conditions of the local population, allowed for the implementation of 
surgical techniques to reduce morbidity. The small cavity technique was found to 
be particularly useful in this respect, as early reports showed the technique to 
more often result in a dry, self-cleaning cavity. 
 
4.2. HYPOTHESES 
• Recent outcomes of surgery for NCCOM at Chris Hani Baragwanath 
Academic Hospital generally reflect those reported in international 
literature. 
• Butterfly cartilage inlay tympanoplasty in our setting, is as successful as 
the reported success rates for fascia underlay graft tympanoplasty. 
• Tympanomastoidectomy for discharging ears is effective to clear the 
discharge but not as effective in achieving an intact tympanic membrane 
post operatively. 
• The small cavity technique in cholesteatoma surgery, with tympanic 
membrane reconstruction, is superior to the large cavity technique without 
reconstruction, in creating a dry care free cavity 
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5. METHODOLOGY 
 
In this chapter, an approach to the research is presented. Patients were grouped in 
terms of the surgical procedure performed. Although the inclusion and exclusion 
criteria were uniform for all three groups, outcome measures and variables studied 
differed as the aim of surgery in the three groups differed as well. The chapter 
will end with a detailed description of the statistical analysis performed. 
 
5.1 STUDY POPULATION AND LOCATION 
The study population included all patients that had surgery performed for Chronic 
Otitis Media at the Chris Hani Baragwanath Academic Hospital (CHBAH) from 
July 2009 to December 2010 (i.e. 18 months). 
 
5.2 STUDY DESIGN 
A retrospective clinical chart review. 
 
5.3 DATA COLLECTION 
Data was collected from the otological database in the outpatient department at 
the CHBAH, and grouped according to surgical procedure performed. These 
groups were: 
• Tympanoplasty, 
• Tympanomastoidectomy, and 
• Canal wall down mastoidectomy. 
 
In all three groups of patients, the clinical and audiological data acquired at the 
last (latest) follow up visit were used. Only data that were collected more than 
two months post operatively were included for study purposes. The follow up 
period varied from 2 to 18 months post operatively. 
 
Except for the CWD mastoidectomy group of patients, audiological data were 
collected only on patients with an intact tympanic membrane post operatively. An 
effort was made to collect all post operative data post CWD surgery as the hearing 
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may have deteriorated post surgery because of the destructive nature of the 
procedure. 
 
5.3.1 Inclusion criteria 
• Patients who had more than one procedure performed on the same or contra 
lateral ear. Each operation was documented on an individualized basis. 
• Patients with pre- and post-operative audiograms. In cases where graft 
failure has occurred, a post-operative audiogram was not a pre-requisite for 
inclusion. 
 
5.3.2 Exclusion criteria 
• All patients who did not fulfill the above inclusion criteria. 
• Patients subjected to ear surgery for reasons other than COM. 
• Cases of staged operations where the middle ear was explored after 
complete healing of the tympanic membrane has occurred. These cases were 
excluded from the study because of the frequent unavailability of 
information about the initial surgical procedures performed.  
• All cholesteatoma patients that had a procedure other that a CWD 
mastoidectomy performed or where the procedure could not be classified as 
being a small- or large cavity technique. The aim of this arm of the study 
was to assess the effectiveness of the small cavity technique in relation to 
the large cavity technique. 
 
5.3.3 Outcome measures 
5.3.3.1 Tympanoplasty 
Tympanoplasty patients were divided into FUG- and BCIG tympanoplasties and 
evaluated independently. Surgical success was defined as a stable, healed, and 
clinically intact tympanic membrane. Improvements in patients’ hearing in the 
speech frequencies (500, 1000 and 2000Hz) were used to report audiological 
outcome. The decibel (dB) measure of hearing in these frequencies were 
averaged and documented pre- and post-operatively. 
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5.3.3.2 Tympanomastoidectomy 
Patients is this group were divided into those, where a discharge was present pre-
operatively and those where the ear was reported to be dry. These were 
independently evaluated post-operatively in terms of dryness of the ear 
(discharging ears), intactness of the tympanic membrane and hearing 
improvement achieved. 
 
5.3.3.3 Canal wall down mastoidectomy 
CWD mastoidectomy patients were divided into small- and large cavity groups, 
and also independently evaluated in terms of dryness of the ear post-operatively. 
In cases where tympanoplasty was performed after disease clearance, intactness 
of the tympanic membrane was documented post-operatively. In cases with an 
intact stapes suprastructure pre- operatively and an intact tympanic membrane 
post operatively, audiological outcomes were studied as well to assess the efficacy 
of the reconstructive effort. Audiological data for cases other than the afore- 
mentioned (perforated tympanic membrane or absent supra structure) was 
collected to assess for possible hearing deterioration. 
 
5.3.4 Variables 
5.3.4.1 Tympanoplasty patients 
• Pre-operative hearing loss. 
• Perforation size. 
• Age. 
• Sex. 
• Status of contra lateral ear. 
 
5.3.4.2 Tympanomastoidectomy patients 
• Age. 
• Pre operative hearing loss. 
• Perforation size. 
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5.3.4.3 CWD mastoidectomy patients 
• Age. 
• Status of contra lateral ear. 
• Extent of disease. 
• Status of Stapes suprastructure. 
 
Some important variables frequently studied have been excluded in this study 
because it is not routinely documented in patients’ files. These include: 
• Whether the ear was quiescent or intermittently discharging pre-
operatively. 
• Whether radiological assessment was used to assess the mastoid bone 
prior to surgery. 
• The status of the middle ear and type of cholesteatoma managed. 
• Surgical experience and grade. 
 
5.3.5 Data analysis 
A descriptive analysis in terms of surgical and audiological success was 
conducted to produce frequency tables and cross tabulations. It was used 
specifically to: 
• Describe the baseline clinical characteristics of the patient population. 
• Determine both surgical and audiological outcomes of surgery within our 
institution. 
• Determine the association between the variables studied and 
surgical/audiological outcome. 
 
Data from the otological database was coded and captured onto an Excel 
spreadsheet and transferred to a Statistica version 12 programme for analysis. 
Normally distributed continuous variables (age, hearing loss and hearing 
improvement post-operatively) were analyzed across the two outcome groups 
using the Students’t-test. Categorical variables (perforation size, extent of disease 
[CWD mastoidectomy], status of stapes suprastructure [CWD mastoidectomy] 
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and status of contra lateral ear [CWD mastoidectomy and Tympanoplasty]) were 
compared across the two outcome groups using the Pearson’s Chi Square test. 
The Fischer’s Exact test was performed when expected cell frequencies were < 
five observations. The correlation co-efficient was used when testing for a linear 
relationship between two continuous variables. 
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6. RESULTS 
 
In this chapter the results of surgery will be presented separately for the three 
groups mentioned, both in terms of pre-operative patient profile and post-
operative surgical and audiological outcomes. Important findings will be 
elaborated on in terms of statistical analysis of results and the drawing of graphs 
for illustration. Although the outcomes of all the surgery performed for COM is 
presented, the focus will be on the parts relevant to the objectives of the study set 
out in section 2. 
  
6.1 TYMPANOPLASTY 
6.1.1 Surgical and audiological outcomes 
In the study period, 43 tympanoplasties were performed. Table 1 describes the 
population in terms of pre-operative hearing loss and type of procedure 
performed. 
 
Table 1: Tympanoplasty: Type of procedure versus pre-operative hearing 
loss 
Hearing loss Tympanoplasty Type 
1 (BCIG) 
Tympanoplasty Type 
1 (FUG) 
Tympanoplasty Type 
2/3 (BCIG+ FUG) 
Total 
     
ACT <30dB 16 3 0 19 
ACT 30- 50dB 10 3 6 17 
ACT >50dB 2 2 1 7 
     
Total 28 8 7 43 
ACT= Air conduction threshold, dB= Decibel, BCIG= Butterfly cartilage inlay graft, FUG= Fascia underlay graft 
 
Most patients had a hearing loss less than 50dB (36/43) and most (27/43) had a 
type 1 BCIG tympanoplasty. The hearing loss pre-operatively in the FUG 
Tympanoplasty group was generally worse than the BCIG group.  
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In cases where Type 1 tympanoplasty was performed, the outcome of surgery in 
terms of surgical procedure (FUG or BCIG) is described in Table 2. 
 
Table 2: Tympanoplasty Type 1: Post-operative outcome. 
Hearing loss BCIG FUG Total 
 P I P I  
      
ACT <30dB 1 23 2 4 30 
ACT 30- 50dB 0 0 0 0 0 
ACT >50dB 0 0 0 0 0 
      
Total 1 23 2 4 30 
ACT= Air conduction threshold, dB= Decibel, BCIG= Butterfly cartilage inlay graft, FUG= Fascia underlay graft, P= 
Perforated tympanic membrane, I= Intact tympanic membrane 
 
23/24 (96%) patients in the BCIG group achieved an intact tympanic membrane 
compared to 4/6 (67%) in the FUG group. In cases with an intact TM, an ACT of 
<30dB post-operatively occurred in 23/23 (100 %) of patients in the BCIG group 
and in 4/6 (67%) patients in the FUG group. 
 
The graph below (Figure 3) compares hearing improvement between the FUG and 
BCIG expressed in percentage terms. 
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Figure 3: Type 1 Tympanoplasty: Hearing improvement comparison: BCIG 
versus FUG 
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Most patients in the BCIG group had less than 10dB improvement (46% of cases). 
3/4 patients (75% of cases) in the FUG group had 11- 20dB improvement in 
hearing. Statistical analysis was not possible, due mainly to a large discrepancy in 
patient numbers. 
 
6.1.2 VARIABLES 
In this series, initial healing of the tympanic membrane (2 months post-
operatively) was uniformly good. The post-operative finding of a high percentage 
of patients with an intact tympanic membrane (91%), made the role that certain 
variables might have had on surgical outcome irrelevant. The relationship 
between the mentioned variables and hearing outcome was studied rather, as it 
was deemed likely that adverse middle ear conditions (adhesions, fluid 
accumulation or retraction of the TM) will manifested as a hearing loss post-
operatively. 
 
6.1.2.1 Age 
Age
<15 years
>15 years
 
Figure 4: Tympanoplasty: age distribution. 
 
The mean age in the tympanoplasty arm of the study was 17 (youngest 6, oldest 
48) 
The scatter graph below (Figure 5), age on the X-axis and HI on the Y-axis, 
illustrates the age distribution in terms of the hearing improvements (in dB) 
achieved. 
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Figure 5: Type 1 tympanoplasty: Hearing improvement versus age 
 
Although most patients were in the younger age group, HI was not shown to be 
related to age (p = 0,935, r- correlation= 0,017).  
 
6.1.2.2 Size of perforation 
Size of perforation
Small <40%
medium 40-
60%
Large >60%
 
Figure 6: Tympanoplasty: Pie chart classifying patients in terms of the size of 
perforation. 
 
Most patients had medium sized perforations. The average HI in medium and 
large perforations was 16,7dB compared to 6,14dB in small perforations. 
Audiological outcome in relation to perforation size is shown in Figure 7. (Y- 
Axis= percentage of patients, X- Axis= HI bins): 
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Figure 7: Type 1 tympanoplasty: Hearing improvement in terms of size of 
perforation 
 
Hearing improvement in patients with small perforations was limited; most (55%) 
had improvements of less than 10dB, where as hearing improvement more than 
10dB was achieved in 70% of patients with medium to large perforations. This 
relationship between perforation size and HI is statistically significant. (p= 0, 
0195) 
 
6.1.2.3 Pre-operative hearing loss 
In patients with a pure conductive hearing loss, with no identified ossicular 
pathology, the association between pre-operative hearing loss and HI are 
demonstrated in the scatter graph below (Figure 8).  
Pre-operative hearing loss is documented on the X- axis and HI on the Y- axis. 
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Figure 8: Type 1 tympanoplasty: Relationship between pre-operative hearing 
loss and hearing improvement post-operatively. 
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A paired T-test was performed on the above data and a statistically, highly 
significant direct relationship was found between pre-operative hearing loss and 
hearing improvement. (p= 0, 0001, r- value= 0,901) 
 
6.1.2.4 Other variables 
No statistically significant relationship was found between sex and hearing 
improvement post operatively (p=0, 77). Whether disease was uni- or bilateral, 
also had no impact on hearing improvement post-operatively (p= 0, 34). 
 
6.1.3 Type 2/3 tympanoplasty 
Seven patients had an ossiculoplasty as a non-staged procedure, of which one was 
lost to follow up. Table 3 below describes the type of ossiculoplasty performed 
and outcomes achieved. 
 
Table 3: Type 2/3 tympanoplasty: Outcomes 
Reconstructive technique TM intact and HI> 
10dB 
Graft failure Audiological failure (no HI) 
PORP Prosthesis (n=3) 0 1 1 
Cartilage (S-I) (n=3) 2 1 0 
Cartilage (S-M/TM) (n=1) 0 0 1 
Porp= Partial ossicular reconstruction prosthesis, TM= Tympanic membrane, HI= Hearing improvement, S-I= Stapes to 
Incus, S-M= Stapes to malleus. 
 
Only 2/6 patients (33%) had significant hearing improvement (>10dB) post 
ossiculoplasty. Both of these cases had minimal ossicular abnormalities (ISJ 
dislocation/fibrous union), and repair was performed by placing a cartilage auto 
graft between the incus and stapes. 
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6.2 TYMPANOMASTOIDECTOMY 
6.2.1 Surgical and audiological outcomes 
In the study period, 33 procedures were performed. 
 
In Table 4, ears are grouped as being dry or discharging, and described in terms of 
pre- operative hearing loss and type of procedure performed. 
 
Table 4: Tympanomastoidectomy: Pre operative characteristics 
Hearing loss Tympanoplasty + Mastoidectomy Mastoidectomy only Total 
Type 1 Type 3 
Dry ears 
     
ACT <30dB 0 0 0 0 
ACT 30- 50dB 2 1 0 3 
ACT >50dB 4 3 0 7 
    
 
Sub Total 6 4 0 10 
    
 
Discharging ears 
No Audio 1 0 1 2 
ACT <30dB 0 0 0 0 
ACT 30- 50dB 6 0 0 6 
ACT >50dB 9 1 5 15 
    
 
Sub Total 16 1 6 23 
Total 22 5 6 33 
BCIG= Butterfly cartilage inlay graft, FUG= Fascia underlay graft, ACT= Air conduction threshold, dB= Decibel. 
 
Most patients had a severe hearing loss (22/33) (67%) and an actively discharging 
ear (23/33) (69%) pre-operatively. All but six patients had reconstruction of the 
tympanic membrane (Tympanomastoidectomy).  
The seventeen tympanomastoidectomy patients presenting with a discharging ear 
pre- operatively, all had fascia underlay graft tympanoplasties. Ten patients had a 
dry ear pre-operatively. All ten patients had ACT’s worse than 30dB and four had 
an ossiculoplasty in the non-staged setting.  
 
 45 
 
Table 5 grouped Tympanomastoidectomy patients post-operatively as dry or 
discharging and in terms of the status of the tympanic membrane and hearing. 
 
Table 5: Tympanomastoidectomy: Post-operative outcome. 
Hearing loss Status of tympanic membrane Mastoidectomy only Total 
Intact Perforated 
Lost to f/u                        3 
Dry ears 
No audio        0        1        1 
       2 
ACT <30dB 9 0 0 9 
ACT 30- 50dB 5 1 0 6 
ACT >50dB 3 3 2 8 
    
 
Sub Total 17 5 3 25 
     
Discharging ears 
No audio 0 1 0 1 
ACT <30dB 0 0 0 0 
ACT 30- 50dB 0 0 0 0 
ACT >50dB 0 1 3 4 
    
 
Sub Total 0 2 3 5 
Total 17 7 6 33 
ACT= Air conduction threshold, dB= Decibel 
 
Dry ears improved from 10/33 (30%) pre-operatively to 25/30 (83%) post-
operatively. 
In patients who had tympanoplasty in addition to mastoidectomy 
(Tympanomastoidectomy), the results were as follow: 
• 18/24 patients had an intact tympanic membrane post- operatively, 10/10 
(100%) dry ears and 7/14 (50%) discharging ears. This difference in 
surgical outcome (Intact TM) between dry and discharging ears was 
statistically significant (p= 0,012). 
• Patients with an ACT of <30dB improved from 0/18 pre-operatively to 
9/18 post- operatively. 
• The average HI in the dry ear group was 20dB as compared to 12dB in the 
discharging group, the difference being statistically significant. (p= 0,02) 
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In order to study the impact that Tympanomastoidectomy had on discharging ears, 
the following outcomes where studied and illustrated in Figure 9 below: 
• Dry ears achieved, 
• Intact tympanic membrane achieved, and 
• Hearing improvement >10dB. 
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Figure 9: Tympanomastoidectomy: Outcome in discharging ears. 
 
Only 50% of discharging ears in this series achieved an intact tympanic 
membrane post- operatively. Significant hearing improvement (10dB) was 
achieved in all seven patients who had an intact tympanic membrane post-
operatively. 
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6.2.2 Variables 
6.2.2.1 Age 
Age
<15 years
>15 years
 
Figure 10: Tympanomastoidectomy: Age distribution. 
 
The majority of patients subjected to Tympanomastoidectomy were in an older 
age group (>15 years of age). No statistical significant relationship was found 
between age and graft success rates (p= 0, 18). 
 
6.2.2.2 Perforation size 
Perforation size
Small
Medium
Large
N/A
 
Figure 11: Tympanomastoidectomy: Distribution of patients in terms of 
perforation size. 
 
Perforation size as a variable was studied to determine whether it had an impact 
on tympanic membrane closure post-operatively. In contrast to the tympanoplasty 
group of patients, the majority of patients in this group had large perforations 
(16/32). 7/15 patients with a large perforation had an intact TM post-operatively, 
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compared to 10/12 patients who had small or medium sized perforations. The 
difference in success rates was statistically significant (p= 0,047). 
 
6.2.2.3 Pre-operative hearing loss 
Figure 12 below illustrates the surgical outcome (Status of tympanic membrane) 
of tympanomastoidectomy in discharging ears in terms of pre-operative hearing 
loss. 
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Figure 12: Tympanomastoidectomy: Surgical outcome for discharging ears. 
 
Only 37% of cases with a hearing loss more than 50dB had an intact TM post- 
operatively, compared to 80% when the hearing loss was <50dB. These results 
were not statistically significant (p= 0,13). 
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6.3 CANAL WALL DOWN MASTOIDECTOMY 
6.3.1 Surgical and audiological outcomes 
In this series, 14 patients had a small cavity- and 19 a large cavity procedure. 
Table 6 describes the procedure performed in terms of the hearing loss pre-
operatively, as well as whether a tympanoplasty was performed in the same 
setting or not. 
 
Table 6: CWD mastoidectomy: Hearing loss and surgical technique.  
Hearing loss Small cavity Large cavity Total 
 Tymp No Tymp Tymp No Tymp  
No audiogram    3 
       3 
ACT <30dB 0 0 1 1 2 
ACT 30- 50dB 4 0 0 4 8 
ACT >50dB 10 0 3 7 20 
      
Total 14 0 4 15 33 
Tymp= Tympanoplasty performed, No Tymp= No tympanoplasty performed, ACT= Air Conduction Threshold 
 
Hearing loss was generally in the moderate to severe range (>50dB) pre-
operatively. 
20/30 (67%) had ACT’s worse than 50dB pre-operatively. Only 4/19 patients in 
the large cavity group had reconstruction of the tympanic membrane, where as all 
the patients in the small cavity group had a fascia graft to the middle ear. 
 
Table 7 describes the outcome for CWD mastoidectomy, in terms of whether the 
ear was dry or discharging and whether the TM was intact post-operatively. 
Patients are grouped in terms of their post-operative hearing loss. 
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Table 7: CWD mastoidectomy: Surgical and Audiological outcome.  
Hearing loss Small cavity Large cavity Total 
 ID IDc PD PDc ID IDc PD PDc  
No audiogram        0  0  0     0     0  0   3    1 
  4 
ACT <30dB 3 0 0 0 0 0 0 0 3 
ACT 30- 50dB 4 0 0 0 1 0 3 0 8 
ACT >50dB 5 1 0 1 2 0 3 6 18 
          
Total 12 1 0 1 3 0 9 7 33 
ID= Intact tympanic membrane and dry, IDc= Intact tympanic membrane but discharge present, PD= Perforated TM and 
dry, PDc= Perforated TM and discharging, ACT= Air conduction threshold, dB= Decibel. 
 
In the small cavity group, 12/14 patients (86%) achieved both an intact tympanic 
membrane and dry cavity post-operatively, compared to only 3/19 (16%) in the 
large cavity group. However, 12/19 (63%) in the large cavity group, still had a dry 
cavity post-operatively. Even though the small cavity group had more dry ears 
post-operatively as compared to the large cavity group, this was not statistically 
significant (p= 0,39). Overall, audiological evaluation revealed no significant 
difference between pre- and post-operative values (p= 0, 31). Three patients that 
had a tympanoplasty performed after a CWD mastoidectomy had hearing 
improvement with an ACT within 30dB post-operatively. Two patients who had 
pre-operative ACT’s <30dB in the large cavity group with no middle ear 
reconstruction, had documented worsening of the hearing to the 30-50dB range. 
 
Table 8 indicates the hearing outcome post CWD mastoidectomy where the stapes 
suprastructure was intact pre-operatively and the tympanic membrane intact post-
operatively. 
 
 
 
 
 
 
 51 
 
Table 8: CWD mastoidectomy: Hearing outcome where stapes 
suprastructure and tympanic membrane intact post-operatively (Type 3 
Tympanoplasty). 
Reconstructive 
procedure 
Hearing 
worse/Unchanged/
<10dB 
improvement 
10-20 dB 
HI 
>20dB HI Total 
Fascia graft only 6 0 1 7 
Fascia graft+ Columella 
(cartilage or incus) 
2 1 2 5 
     
Total 8 1 3 12 
 
3/12 patients had more than 20dB improvement and 1/12 had 10-20dB 
improvement. Overall, post operative ACT’s were significantly better in ears with 
an intact suprastructure as compared to those without (p= 0,004). 
 
6.3.2 Variables 
6.3.2.1 Age 
Age as a variable was studied to determine if it was related to the extent of the 
cholesteatoma or not. In this series, cholesteatoma was evenly distributed over all 
ages. (Figure 13) 
Age
<15 years
>15 years
  
Figure 13: CWD Mastoidectomy: Age distribution 
No statistically significant relationship existed between Age and Extent of disease 
(p= 0, 84) 
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6.3.2.2 Status of contra lateral ear 
Status of contra-
lateral ear
Normal
Cholesteatoma
Perforation
Adhesive OM
 
Figure 14: CWD mastoidectomy: Pathology opposite ear 
 
The status of the contra-lateral ear in this series of cholesteatoma showed that the 
majority had unilateral disease with a normal contra-lateral ear. The majority of 
the pathology in patients with bilateral disease presented with cholesteatoma in 
the opposite ear as well. 
 
6.3.2.3 Extent of disease 
Cholesteatoma extension to the mastoid region was encountered in 12 of 29 
patients. Only 6 of 29 patients presented with small attic cholesteatoma (Figure 
15). 
Extent
Attic
Antrum
Mastoid
NCCOM
N/A
 
Figure 15: CWD mastoidectomy: Cholesteatoma extent. 
 
No statistically significant relationship was found between extent of disease and 
the outcome of surgery (discharging or dry, post-operatively) (p= 0, 63). 
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6.3.2.4 Status of the stapes suprastructure 
The status of the suprastructure was studied as a variable, as hearing outcome is 
thought to be related to this variable. 
Status of stapes supra 
structure
Intact
Eroded
N/A
 
Figure 16: CWD mastoidectomy: Status of the stapes suprastructure. 
 
A large number of patients had stapes erosion (9/23). 14/23 patients had an intact 
suprastructure. In 10/33 patients, the status of the suprastructure was not 
commented on. 
No patients in this study had hearing improvement in the absence of a 
suprastructure. In cases with an intact suprastructure, hearing outcome is shown in 
Table 7. 
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7. DISCUSSION 
 
A discussion of the most important findings of this study will follow in this 
chapter. Again, the three groups of patients will be discussed separately, both in 
terms of the surgical, and audiological outcomes achieved. Where appropriate, 
these outcomes will be discussed in relation to those reported in the literature, 
after which possible explanations will be forwarded as to the results achieved in 
this study. Recommendations may then be made regarding the future surgical 
management of patients in our setting.  
 
The focus of the discussion will be on the areas mentioned in section 2, which 
include the following: 
• BCIG tympanoplasty for simple perforations. 
• Tympanomastoidectomy for actively discharging ears. 
• Small cavity canal wall down mastoidectomy for advanced cholesteatoma. 
 
7.1 TYMPANOPLASTY  
Tympanoplasty techniques and grafting materials have evolved over time to a 
point currently where the FUG is the gold standard. (24) Fascia is effective and 
appropriate for the majority of patients with tympanic membrane perforations, 
and has been the choice grafting material for more than 60 years. 
 
Cartilage on the other hand, also used in middle ear surgery for a very long time, 
has only recently become a regular choice of tympanic membrane grafting 
material in some centres. (41) Its previously perceived inferior, sound conducting 
properties contributed to many avoiding it as grafting material. Audiological 
outcomes, shown to be equivalent to FUG tympanoplasty however, led many to 
use it on an increasingly regular basis for simple perforations. In this regard, the 
BCIG technique, being simple and effective proved to be particularly useful. In 
addition, its rigidity and resilience in a hostile middle ear environment presents 
significant advantages over fascia as grafting material. 
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7.1.1 Surgical and audiological outcomes 
In the literature, numerous studies have been published regarding the BCIG 
technique, since it was first described in 1998. Its initial description for pediatric 
patients was extended to adults where the procedure was performed as a 
minimally invasive procedure under LA and on an outpatient basis. (39, 42, 43) 
The outcomes of studies regarding the BCIG technique are summarized in Table 
9. 
 
Table 9: BCIG tympanoplasty outcomes (Literature review) 
Study Graft success Audiological success 
Pre operative Post operative 
Present study (n= 30) 93% PTA <30 dB 53% 
PTA 30- 50dB 40% 
PTA >50dB 7% 
PTA< 30 dB 100% 
Wang et al. (n= 28) (43) 85%  Change in ABG 
< 10dB 71% 
11-20dB 25% 
>20dB 3.6%  
Coulognier et al.(n=49) (38) 71%  ABG within 20dB 92% 
Monfared et al. (n=145) (39) 67% Average PTA 37dB  Average PTA 28dB 
Anand et al. (n=20) (66) 90% PTA <30 dB 50% 
PTA 30- 50dB 50% 
PTA< 30dB 100% 
Lin et al. (n=71) (40) 87%  ABG closure index(pre op ABG-post 
op ABG/Pre op ABG) 
<0% 20%, 0-25% 15%, 25-50% 25%, 
50-75% 15%, 
75- 100% 25% 
Ghanem et al. (n=99) (41) 92% ABG <20dB 43% 
ABG 20-40dB 45% 
ABG> 40dB 11% 
ABG <20dB 51% 
ABG 20- 40dB 38% 
>40dB 10% 
Mauri et al. (n=34) (42) 85% ABG <20dB 56% 
ABG 20-40dB 44% 
ABG> 40dB 0% 
ABG <20dB 94% 
ABG 20- 40dB 6% 
>40dB 0% 
PTA= Pure tone average, ABG= Air-Bone-Gap, dB= Decibel 
 
From the above-mentioned studies, the BCIG technique for centrally located 
small to medium sized perforations (<4mm), has proved to be very effective both 
in terms of surgical and audiological outcomes. Its role in large perforations 
however is still uncertain, as mixed results have been reported. The following 
paragraphs will focus on its use in larger and peripherally located perforations.  
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Controversies exist regarding the outcome of tympanoplasty for large perforations 
in general. Although many studies have shown no difference in closure rates 
between small and large- or anterior located perforations (7,17,20,22), a recently 
published large retrospective power analysis of more than 400 cases found 
surgical success rates in 74% of small perforations and 56% of large perforations 
(FUG technique). (67) These authors concluded that most studies reporting 
equivalent results between large and small perforations, either were of a non-
controlled nature or included too few patients to make a conclusion.  
 
The numerous cartilage-grafting techniques (36) have shown promise in the 
reconstruction of large- or anteriorly located tympanic membrane perforations as 
well, as its rigidity proved particularly useful in such ears. Unfortunately, most of 
these techniques require significant surgical skill, experience and time to perform 
well. 
 
As mentioned, because of the effectiveness of the BCIG technique for small 
simple perforations, an expansion of indications occurred to include more 
challenging perforations and pathology. With regards to larger perforations, some 
authors found surgical success to be higher in smaller perforations than larger 
ones, (38, 39) while others have shown no difference in success rates when this 
variable was studied. (40, 41) 
 
Both the authors who related success rate to size of perforation, concluded that the 
technique as originally described should be used with caution in large 
perforations. One of these two studies included 145 patients where the procedure 
was performed under LA in an office setting. They concluded that residual 
perforations were frequent in perforations larger than 4mm in diameter, and 
increased almost linearly with size of perforations. Perforations larger than 6mm 
had only a 44% success rate in their series. Although the authors did not mention 
possible theories as to why these perforations occurred, they did state that the 
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procedure in their opinion is contra indicated when the perimeter of the 
perforation can not be inspected adequately. (39)  
 
In our experience with the technique, a possible explanation for residual 
perforations in large defects, as described by the authors of the above study, is the 
inadequate exposure offered by an operating microscope in a trans canal 
approach. The difficulty associated with the procedure in such cases is likely to 
result in inaccurate placement of the graft with subsequent failure. 
 
The other study relating success to perforation size was performed for pediatric 
patients with simple perforations. In this study of 57 patients, all perforations 
included were those that were non-marginal where a clear view of the entire 
perforation perimeter was possible with a single trans canal view. Size of 
perforations was not a criterion for inclusion. They reported that most of their 
failures, albeit few, occurred after closure of larger perforations and that these 
perforations were recurrent rather than residual ones. They explained this finding 
by speculating that the process of epithelization over perichondrium is generally 
slow, and that the prolonged absence of epithelial covering over some of the 
perichondrium resulted in parts of the graft to necrose and perforate. To this 
extent, the authors suggested that a STSG is necessary in such cases, to facilitate 
the epithelisation process. (38) 
 
Although a limited population size, the complications of myringitis and recurrent 
perforations in the closure of large perforations were absent in the present series. 
A possible explanation for this finding may be the routine and prolonged use of 
topical antibiotics in the post-operative period. We believe that this practice, in 
addition to preventing infection and necrosis of the cartilage graft, will also 
facilitate epithelisation by keeping the graft moist until complete healing has 
occurred. 
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In addition to the risk of recurrent or residual perforations with the BCIG 
technique, the theoretical risk of cholesteatoma formation by epithelial 
entrapment remains a danger of this technique, especially in marginal 
perforations. (39) Although none of the three studies with adequate long term 
follow up (2 years on average) reported any cases of cholesteatoma formation, (38-
40)
 at our institution we tend to err on the side of caution when addressing large or 
marginal perforations.  
 
It is our policy to anchor the graft on the bony annulus when the perforation 
approaches the annulus. The fibrous annulus is lifted out of its sulcus and draped 
back over the graft post placement, resulting in what can be described as a 
combination of an inlay and underlay technique. Performing the procedure in this 
way may reduce the chances of epithelial entrapment at the margins of the 
perforation. We consider the afore- mentioned technique particularly important 
when dealing with large or subtotal perforations as post-operative middle ear 
surveillance for cholesteatoma formation may be difficult with a large opaque 
graft in situ. (41) 
 
Only one study to date has explored the use of the BCIG as part of a formal 
tympanoplasty technique. (41) The authors of this study included 99 patients with 
large perforations, the bulk of which (70%) needed a canal wall up 
mastoidectomy, and a retro auricular approach to the middle ear. Half the patients 
in this particular study presented with cholesteatoma. They achieved a perforation 
closure rate of more than 90% in spite of the fact that most patients had extensive 
middle ear disease. The authors mentioned that in most cases, the graft needed 
anchoring on annular bone and that because of the size of the perforation, also 
required a STSG to cover the graft. They reported no retraction pocket formation 
or graft dislodgement in the post-operative period. In their conclusion, the authors 
mentioned that a comparative study with fascia was not possible as, because of 
BCIG being the preferred technique, they performed too few such 
tympanoplasties in the study period. 
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The outcomes of the above study confirms our observation that exposure with the 
BCIG technique, as is the case with all types of ear surgery, plays a critical role in 
the achievement of consistently good results. This is especially the case when 
dealing with large or marginal perforations. 
 
In addition to the observations made above, we identified some additional points 
regarding the BCIG technique itself that may increase the safety and/or the graft 
success rates in challenging perforations: 
• A retro-auricular approach and canaloplasty may improve exposure, 
especially in the anterior portion of the TM, but we have found that the 
use of an endoscope (0- or 30- degree) result in superior exposure and 
more accurate placement in this difficult to access area. In addition, 
inspection of the perforation rim is optimized and the risk of epithelial 
entrapment minimized.  
• The scissor harvesting of large pieces of cartilage (especially tragal), may 
result in a fractured graft with poor stability. Performing sharp dissection 
rather, may more often result in a cartilage graft that maintains its rigidity 
and that locks into position more securely. 
• When dealing with large perforations, literature suggests the leaving of 
perichondrium on one side of the graft only, (36) as this may minimize the 
adverse effects that a very thick graft may have on sound conduction. In 
this series and  others, (38, 39, 67) cartilage with the perichondrium left intact 
on both surfaces was used when repairing such perforations. Besides not 
affecting sound conduction negatively, it also seems to allow the cartilage 
to maintain its original shape and rigidity.  
• Post-operative dislodgement or residual perforations may result from an 
inaccurately prepared graft. A saline flush to the placed graft under direct 
endoscopic vision, may help to detect residual perforations or unstable 
areas that may lead to dislodgement post-operatively. One can then either 
“patch” such defects with additional cartilage, or one can harvest a new 
graft to repair the original defect. 
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As mentioned, comparative studies have shown that similar hearing 
improvements are possible between cartilage and fascia, independent of graft size. 
(35) This is also the suggestion from this series, as sociable hearing (ACT< 30dB) 
was achieved in all patients subjected to a type 1 BCIG tympanoplasty. This 
finding is in accordance with the available literature on BCIG specifically (see 
Table 9) and suggests that factors other than grafting material determine hearing 
outcome in most patients.  
 
We postulate that the good hearing outcomes with the BCIG technique are due to 
a combination of factors, which may include the avoidance of middle ear packing, 
and the maintenance of the TM in its anatomical position. Both these factors will 
facilitate unrestricted ossicular movement in a large middle ear space free of 
adhesions. 
 
7.1.2 Variables 
As mentioned, the size of the perforation and cartilage graft did not negatively 
affect hearing gains in the present study. In fact it was found that hearing 
improvement was directly related to the size of the perforation in that the larger 
the perforation the more the hearing gain (p= 0, 0195). One study observed 
similar findings and postulated that the significant hearing improvements seen 
with large BCIG’s, are due to the cartilage graft contacting the malleus directly, 
resulting in a phenomenon they call the “4th ossicle effect”. (40) 
 
Following on from the above finding, is the observation of a direct linear 
relationship between pre-operative hearing loss and hearing improvement post 
operatively (r= 0,901). Statistical analysis further revealed these results to be 
strongly significant (p<0, 0001), confirming the fact that hearing gains are 
independent of grafting material. No studies in the researched literature 
investigated this relationship to identify factors that may affect outcomes. It may 
have been interesting if this relationship was studied for Type 1 FUG 
tympanoplasty. In such cases, the entering and packing of the middle ear may 
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result in adhesions to form, effectively reducing the middle ear space and 
attenuating hearing gains post-operatively. 
 
Debate exists as to the outcome of tympanoplasty in the longer term. In pediatric 
cases, contradictory findings exist, as some report no deterioration over the longer 
term, (8) whereas others found hearing to deteriorate frequently, secondary to 
recurrent OME and perforations. (17) Age in the pediatric population specifically, 
may be important in this respect, as some have found that older children (10-14 
years) have better long term hearing outcomes than younger ones (2-10 years). (18)  
 
In the present series most patients were in the pediatric age group (<15 years of 
age) and follow up periods were short (<1 year). Accepting that at least some 
patients will develop recurrent middle ear disease and hearing deterioration in the 
future, it is our belief that overall patient management has not been compromised. 
With the BCIG technique, redo surgery is likely to be uncomplicated, as the 
absence of external ear incisions and an undisturbed external ear canal, will 
simplify any further surgery. Furthermore, unnecessary entrance into, and packing 
of the middle ear is avoided, resulting in most patients having an undisturbed 
middle ear cleft that may facilitate a possible future tympanotomy and/or 
ossiculoplasty. 
 
7.1.3 Type 2/3 tympanoplasty 
7.1.3.1 Limited lenticular process erosion 
As mentioned, to repair this type of ossicular defect (Type 2 tympanoplasty), a 
variety of materials may be used. In the present series, cartilage was used to repair 
two cases presenting with ISJ erosion. A satisfactory outcome (ACT<30dB) was 
achieved in both. Although most authors prefer the use of allogenic prosthesis’ or 
cement to repair such defects, cartilage is readily available, easy to sculpture and 
shown to result in equally good hearing outcomes. (31) 
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7.1.3.2 Extensive ossicular erosion 
 In the absence of active middle ear infection or Eustachian tube dysfunction, 
according to the MERI system, outcomes of ossiculoplasty are dependent on 
extent of ossicular erosion and the presence of a perforation. In the case of a 
perforation with both an intact malleus long process and stapes suprastructure 
present, most will prefer one-stage surgery to repair the defect.  
 
Frequently however, the perforation may be large, the malleus handle 
medialized/eroded, and the stapes suprastructure absent. Although not seemingly 
affecting results in the literature (1, 70) these factors may have been a major factor 
to account for the poor outcomes in this series. In this respect, a change in 
approach may be necessary to improve outcomes. As was the findings in some 
studies, (68) staged surgery in our setting may yield superior results as one can then 
avoid the additional difficulties associated with prosthesis placement and TM 
grafting in a compromised middle ear cavity. In this respect, although our 
experience with ossiculoplasty as part of a BCIG tympanoplasty is limited, we 
believe that it can potentially be superior to the FUG tympanoplasty in such a 
staged setting. In at least some of such cases, the intact cartilage graft on the 
lateral aspect of the prosthesis will help with initial stabilization and prevent later 
extrusion. (28) The absence of adhesions will further facilitate placement of the 
prosthesis. 
 
Only one study reported outcomes of ossiculoplasty combined with a BCIG 
technique. They reported good surgical and audiological outcomes in such cases, 
but unfortunately did not mention whether surgery was staged or not. Neither 
extent of ossicular pathology nor the techniques or materials used to repair it were 
mentioned either. (41) 
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7.2 TYMPANOMASTOIDECTOMY 
7.2.1 Surgical outcomes  
Even though no scientific evidence exists for the exenteration of mastoid air cells 
to improve all tympanoplasty outcomes, this is still common practice. (12) If one 
considers literature evidence on the subject, it is clear that although 
mastoidectomy will be beneficial in certain cases of tympanoplasty, a subgroup of 
patients exists where its role remains uncertain.  
 
The following discussion will focus on the outcomes of tympanomastoidectomy 
in different clinical situations. 
 
7.2.1.1 Actively discharging ears 
In actively discharging ears with gross disease in the middle ear (granulation 
tissue, muco-purulent pus), except for one researched article, (12) most authors 
have shown that a mastoidectomy is necessary to achieve the goal of a dry ear (5, 6, 
9, 10)
, both in the early and late post operative period. (9) This was also the finding 
in the current series where dry ears were achieved within 2 months of surgery in 
the majority of such cases (10/12 patients).  
 
Concerning graft take rates however, in contrast to most studies that report very 
good outcomes (see Table 9), (9, 10) an intact TM was achieved in only 50% of 
discharging ears in this series. Some of the reasons that may explain these results 
are discussed below. 
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Table 10: Summary of studies that describe outcomes in dry and discharging 
ears post tympanomastoidectomy. 
Study Active NCCOM Inactive NCCOM 
Graft success Audiological 
success 
(ACT< 30dB/ ABG 
<20dB 
Graft Success Audiological 
success 
(ACT<30dB / 
ABG<20dB) 
Present study (n= 22) 50% 50% 100% 80% 
Krishnan et al. (n=76) (5) 80% 75% 100% 80% 
McGrew et al. (n=131) (15)   92% 80% 
Mishiro et al. (n=147) (12) 90% 82% 91% 82% 
Balyan et al. (n=28) (13) 85% Ave ABG 20dB   
Ruhl et al. (n=47) (10) 90% 81%   
ACT= Air Conduction Threshold, ABG= Air-Bone-Gap, dB= Decibel 
 
Firstly, certain clinical parameters indicate that the severity of disease managed in 
the current series may have been more severe than that of the mentioned studies. 
Considering pre-operative hearing loss in this respect, an interesting finding may 
explain at least some of the outcomes. It is evident from this series that surgery 
resulted in an intact TM in only 37% of cases presenting with a severe hearing 
loss (ACT >50dB). These results, compared with cases where a mild or moderate 
hearing loss (ACT 30- 50dB) were present (80% achieving an intact TM), 
although not statistically significant (p= 0, 13), may support the possibility that 
disease severity affected outcomes and that it may have been worse than in the 
studies mentioned in Table 10. 
 
A second reason may relate to the inadequacy of surgery in our setting. Two of 
the studies that reported very good results with standard fascia underlay grafting 
(>80% graft take rate), performed a complete air cell exenteration and posterior 
tympanotomy to clear disease (9, 11). In the present study, even though attempts 
were made to remove all obvious granulation tissue in the mastoid and to 
establish attic patency, most cases had neither a full mastoid air cell exenteration 
nor a posterior tympanotomy performed. It may thus be, that retained diseased air 
cells and persistent poor mastoid to middle ear drainage resulted in at least some 
of the grafts to fail. 
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A third possible reason that may explain the poor graft survival rates in this series 
relate to certain patient specific factors. The role that systemic and regional 
factors may play on the outcome of surgery is illustrated by a large study on the 
long-term outcome of tympanomastoidectomy in the pediatric population. (6) The 
authors of this study also found high rates of residual perforations and concluded 
that in their series, tympanomastoidectomy did not cure the actively discharging 
ear completely. The developing immunity and challenging anatomic conditions in 
the postnasal space of pediatric patients may not only have explained their results, 
but may also point to the role that similar conditions may play in our patient 
population. Poor socio-economic conditions and high sub-clinical HIV infection 
rates may also have played a role in the outcome of surgery in this series. 
 
7.2.1.2 Dry and quiescent ears 
Existing evidence that mastoidectomy in dry and quiescent ears does not 
influence outcomes, may be true in selected ears only. From the literature and this 
series on NCCOM, little doubt exists that an expertly performed tympanoplasty 
for a simple tympanic perforation (no discharge, middle ear disease and ossicular 
pathology) of any size, with or without mastoidectomy, (15) can be expected to 
result in a healthy and intact tympanic membrane post- operatively.  
 
Many ears however have some degree of tympanic membrane retraction, 
atelectasis, quiescent middle ear changes and/or disproportionate hearing loss that 
complicates decision making as to the appropriate surgical procedure. Although 
many studies in the past attempted to establish the role of mastoidectomy in dry or 
quiescent ears, none controlled for all the above variables and therefore are 
difficult to interpret.  
 
In the present study also, no conclusion could be drawn as to the role of 
mastoidectomy to improve tympanoplasty outcomes. Some of the reasons include 
following: 
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• Many surgeons are involved in the surgical assessment and treatment of 
patients with COM in our institution. The different opinions regarding the 
management of patients frequently result for instance in one patient to be 
subjected to a tympanomastoidectomy, while another with similar 
pathology, receives a tympanoplasty alone after assessment by a different 
surgeon.  
• Incomplete and/or inaccurate pre- operative details regarding the status of 
the middle ear were frequent and did not allow for outcomes to be 
compared post operatively. 
 
7.2.2 Audiological outcomes 
7.2.2.1 Type 1 Tympanomastoidectomy- dry ears 
The audiological outcome post Type 1 Tympanoplasty in dry or quiescent ears (as 
discussed in section 7.1.3), is not only a factor of disease extent and the 
management thereof, but is also related to the aeration of the middle ear post 
surgery. A mastoidectomy to improve middle ear aeration may be effective to 
keep hearing stable over the longer term, (15) but studies have shown no difference 
in hearing outcome between tympanomastoidectomy and tympanoplasty alone in 
the early post-operative period. (12) In cases with an intact tympanic membrane 
post-operatively then, one can expect similar hearing outcomes in these two 
groups of patients. (12, 13) The addition of a mastoidectomy to the tympanoplasty 
procedure is unlikely to benefit the patient if the sole purpose is to augment the 
hearing gain achieved.  
 
Unfortunately, a direct comparison between the audiological outcomes in dry ears 
for the Tympanoplasty- (30 patients, average HI 12,5dB) and 
Tympanomastoidectomy (4 patients, average HI 23dB) groups of patients in this 
series was not possible because of the following reasons: 
• Large discrepancy in patient numbers, 
• Pre operative hearing loss and perforation size not controlled for 
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7.2.2.2 Type 3 Tympanomastoidectomy-discharging ears 
In contrast to the above, controversy arises in the management of cases where 
ossicular chain abnormalities exist in active COM. Not only may the diagnosis of 
ossicular pathology be compromised in these circumstances, but also the repair 
and surgical outcomes. (28)  
 
Staged surgery plays an important role in these circumstances as it is hoped to 
result in a healthy, closed and well-aerated middle ear that will facilitate 
reconstruction in future. Frequently however, especially in severely diseased 
middle ears, it may also result in shallow middle ear clefts with adhesions (52) and 
residual perforations that may negatively affect the outcome of a staged 
ossiculoplasty. In addition, one may then be committed to the use of allogenic 
materials, as often the incus may have been sacrificed in the process of 
establishing attic patency. 
 
These observations, as well as the fact that most patients prefer a single operation, 
have led many to perform non-staged surgery even in active COM. (27) In the 
literature, results for non-staged surgery in such cases vary, as some report very 
good outcomes, (27) while others mention that staged surgery, especially in 
pediatric patients, (68) will result in superior audiological outcomes.  
 
At CHBAH, staged surgery is frequently the preferred approach (the outcomes of 
which is not included in this study), non-staged surgery being performed very 
infrequently (only one patient in current series). Of the eight patients planned for 
staged ossiculoplasty post tympanomastoidectomy, only 3 (37%) achieved an 
intact tympanic membrane post operatively.  
 
In view of the above-mentioned arguments and results that suggest that residual 
perforations and adhesions indeed frequently complicates staged ossiculoplasties, 
the best management in our setting may be one that incorporates both approaches.  
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In future, outcomes may be improved if the choice between staged and non-staged 
surgery is individualized and based on disease extent, the availability of 
autologous grafting materials (e.g. incus), and surgical capabilities. As 
mentioned, the use of the BCIG tympanoplasty to reconstruct the tympanic 
membrane may be particularly beneficial to improve graft take rates and 
outcomes achieved in staged surgery. (See section 7.1.3.2) 
 
7.2.3 Variables 
Because extent or severity of disease is difficult to define, one aim of this study 
was to find measurable variables that may mirror extent of disease and therefore 
may predict outcome. Advancing age, pre operative hearing loss and size of 
perforation were postulated to affect surgical outcome by virtue of the likelihood 
of severe middle ear disease being present in such ears. 
 
In the present series, although significance could not be established (p= 0, 13), the 
results indicated a possible relationship between pre-operative hearing loss and 
surgical success (graft take rates) in discharging ears but not in dry ears. As 
mentioned, in the discharge group, it was found that ACT’s worse than 50dB 
resulted in more surgical failures as compared to cases were ACT was better than 
50dB (37% vs. 80% respectively). An explanation for this finding may be the 
possibility that at least some patients experiencing a failed procedure, suffered 
from “end stage COM pathology” where permanent damage to the middle ear 
mucosa and/or mastoid resulted in poor healing post-operatively. In the literature, 
multiple failed tympanoplasties or adhesive otitis media are often attributed to end 
stage COM. (28) In our setting, it may be that improved patient selection will 
improve surgical outcomes in future.  
 
In the case of age as a possible predictor of surgical outcome, we could find no 
statistical significance linking age and graft success rates (p= 0, 18). This was also 
the finding in the studied literature. 
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Although size of perforation was not found to influence success rates in the 
tympanoplasty arm of the study, a statistically significant relationship was found 
in the tympanomastoidectomy arm of the study (p= 0,047). It may be that size of 
perforation mirrors pre-operative hearing loss and that the two variables may 
combine to indicate severe middle ear disease and predict a poor surgical 
outcome. 
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7.3 CANAL WALL DOWN MASTOIDECTOMY 
7.3.1 Motivation for small cavity technique 
CCOM is a destructive disease process that frequently results in a severe hearing 
loss and considerable morbidity. In addition, life-threatening complications may 
occur in untreated disease. Surgery therefore plays a very important role, not only 
to reverse the ongoing destructive process, but also to improve patients’ quality of 
life. During cholesteatoma surgery, although disease eradication and complication 
prevention (creation of a safe ear) should be the focus of attention, significant 
morbidity reduction and hearing improvement are possible as well. Even in the 
presence of advanced disease, the many described surgical options available to the 
surgeon should allow for the creation of a carefree ear and hearing improvement 
in the majority of patients. 
 
In our setting, these surgical options however, are subject to many variables that 
may influence the outcome of surgery. Of these, poor patient compliance and 
limited resources may have been factors in the past that played a central role in 
the perceived poor outcomes of surgery for cholesteatoma. Although resources 
(equipment, theatre time and staff) are considered adequate at present, patient 
compliance in the current setting is still uncertain over the long term. The 
introduction of expansive surgical and reconstructive techniques (i.e. CWU 
surgery) to reduce morbidity is therefore difficult to implement as not only may it 
compromise the safety of the procedure, but inadequate follow up will also 
hamper surgical progress. In order to improve morbidity and surgical outcomes 
therefore, an improvement in CWD surgery technique is more appropriate. 
 
Approaching disease through the mastoid cortex in a back to front fashion and 
removing the canal wall at the end, although providing the best exposure to the 
epitympanum for safe cholesteatoma removal, also results in a cavity that has 
little chance of being dry and self-cleansing. (59) As acknowledged in the 
literature, obliteration of the cavity is a vital step to improve outcomes of surgery 
performed in this way. (47, 51, 53) Since obliteration is seldom a consideration in our 
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setting, the small cavity technique may effectively address the shortcomings of 
the large cavity technique. 
 
In advanced cholesteatoma, drilling is limited to the size of the cholesteatoma, 
and early identification of important facial nerve landmarks results in safe facial 
nerve skeletonization and lowering of the facial ridge. This provide for accurate 
and complete middle ear cholesteatoma removal, which in turn allows for grafting 
of the tympanic membrane in almost all the procedures performed in this way. 
These steps combine to create a carefree cavity post-operatively in most cases. 
 
In limited cholesteatoma, its similarities to the CWU technique are obvious, 
except for the fact that a full mastoidectomy is not performed and disease is 
exteriorized. (57, 58) Both of these factors combine to reduce recurrence rates, 
improve safety and negate the need for planned relook procedures. 
 
7.3.2 Surgical outcomes 
In the literature, comparing results between the large- and small cavity techniques 
is difficult as the extent of disease managed frequently differs between these two 
groups of patients. Except for a few, (33, 51) proponents of the large cavity 
technique, utilize the procedure mostly in advanced cholesteatoma (47, 54, 63) and 
reserve a CWU technique for patients with limited disease. Proponents of the 
small cavity technique mostly employ the procedure in all cases of cholesteatoma 
managed.  
 
Although literature suggests that similarly good surgical results are achievable 
regardless of CWD mastoidectomy technique used (see Tables 11 and 12), the 
extent of surgery required, differs greatly between techniques. For instance, 
smaller cholesteatomas managed with a small cavity CWD technique are far less 
demanding than managing an acutely infected, extensive cholesteatoma with a 
large cavity technique. 
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Table 11: Summary of studies mentioning outcomes for CWD 
Tympanoplasty with complete air cell exenteration and obliteration with 
temporalis muscle flap (Large cavity or “Fisch technique”) 
Study Dry ear Stapes 
eroded 
Graft 
success 
Audiological success 
ABG< 20dB Mean PTA 
improvement(dB) 
Present study (n=15) 66% 50% 16% 0% N/A 
De Zinis et al. 
 (n= 189) (51) 
95% 57% N/A 44% N/A 
Nyrop et al. (n=27) (54) 89% 52% N/A N/A 12,5 
Kos et al. (n=259) (33) 95% 30% 94% 31% N/A 
Berenholz et al. (n=33) (63) N/A 45% N/A 63% 12,3 
Vertiainen et al. 
 (n= 297) (47) 
N/A 25% N/A 44% 6 
Lau et al. (n=64) (49) 81% 63% 8% 24% N/A 
      
dB= Decibel, ABG= Air Bone Gap, N/A= Not available 
 
Table 12: Summary of studies mentioning outcomes for CWD 
mastoidectomy using “small cavity” technique 
Study Dry ear Stapes 
eroded 
Graft 
success 
Audiological success 
ABG< 20dB Mean PTA 
improvement(dB) 
Present study (n=18) 87% 50% 92% 21% N/A 
Roth et al. (n=604) (57) 93% 25% 97% N/A 12 
Grewal et al. (n=600) (50) 91% 30% 91% N/A >10dB PTA 
improvement 70% 
De Corso et al. (n=142) (61) N/A 31% N/A 69% 12,4 
Shrestha et al. (n= 77) (32) N/A 0% 94% 65% N/A 
      
dB= Decibel, ABG= Air Bone Gap, N/A= Not available 
 
This was indeed the case in some of the small cavity CWD mastoidectomy 
studies, where the bulk of the patients had limited disease with relatively small 
cavities and well preserved middle ears post-operatively. (57, 61) Comparing results 
of these studies with those of certain large cavity technique studies (47, 51) will not 
give a true reflection of the superiority of one technique over the other. 
 
One study however described their experience with the small cavity procedure in 
patients with mostly extensive cholesteatoma and reported equally good results to 
those achieved by proponents of the large cavity technique. (50) They included 600 
patients in their study and reported dry and trouble free ears in over 90% of 
patients. Recurrence rates were low and comparative to the number frequently 
quoted in the literature for the large cavity technique (5-10%). 
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Most of the ears in the small cavity arm of this study also had advanced 
cholesteatoma (79%), which required a complete CWD (facial ridge taken down 
in its entire length in the mastoid) procedure with cavity saucerisation. Performing 
this surgery in a front to back fashion, we found that the deliberate retention of 
non-diseased or sclerotic air cells in the sino-dural angle and mastoid tip, kept the 
cavity small and cylindrical. By removing the cortical bone around the meatus 
sparingly, the meatus could be kept small enough to avoid the morbidity of an 
excessively large one, but large enough to provide adequate aeration and 
surveillance of the created cavity. 
 
Our results for the small cavity technique for advanced cases as described above, 
reflects those reported by others where a similar technique was used (see Tables 
11 and 12) and was far superior to the large cavity technique in this series. 
Accepting that most of the large cavity technique patients had surgery that can be 
considered incomplete (no cavity obliteration or tympanic membrane 
reconstruction), from this study, at least in the short term, the small cavity 
technique is a valuable alternative for patients with advanced cholesteatoma. 
Although the long-term safety of the procedure is still uncertain in our setting, 
literature evidence exists that recurrence rates will mirror that of the large cavity 
technique. (50) The exteriorization of disease in all cases will likely prevent serious 
complications should follow up issues occur.  
 
7.3.3 Audiological outcome 
When evaluating and comparing audiological outcomes between studies on CWD 
surgery, the consideration of some disease- and surgical factors are important. 
From the studies mentioned in the above two tables (Tables 11 and 12), it is clear 
that mainly two factors need consideration. 
 
Firstly, one needs to consider the prevalence of the stapes suprastructure in the 
particular study and the reconstructive techniques employed to repair the ossicular 
defect. From the literature, an intact suprastructure is particularly important. 
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Performing even a simple type 3 tympanoplasty (32, 33) in such cases may result in 
significant hearing gains. Adding a cartilage columella graft, these gains can be 
enhanced, in most cases to a level where sociable hearing is possible. This fact is 
illustrated in a study on the subject where the latter group of patients was found to 
have significantly more hearing improvement than the former. The authors 
concluded that the superior audiological outcomes achieved with cartilage 
augmentation, are secondary to the increase in the effective vibrating area of the 
TM that a cartilage plate provides. (28)  
 
In the absence of a suprastructure however, with some exceptions, (28) results seem 
to be heavily dependent on reconstructive techniques. With exceptions, studies 
that employed a high percentage of Type 4 tympanoplasty (47, 49, and 51) in such 
cases seem to achieve worse results as when major columellas (TORP’s) were 
used liberally. (57, 61, 63)  
 
One exception to the above is a study that included 40 patients with stapes 
suprastructure erosion subjected to a CWD mastoidectomy. They found no 
difference in audiological outcomes, irrespective of whether a type 4- or major 
columella tympanoplasty was performed. (28) They mentioned that a major 
columella (TORP) is preferred when the oval window niche is deep, as opposed to 
a Type 4 tympanoplasty when the footplate lies shallow in the niche. 
 
A second factor for consideration when evaluating audiological outcomes is the 
extent of cholesteatoma and middle ear mucosal disease dealt with. Post-operative 
scarring in severely affected middle ears frequently results in poorly aerated 
shallow middle ear clefts that in turn negatively affect sound transmission to the 
inner ear. (51) Authors who reserve CWD mastoidectomy for cases with extensive 
ossicular defects (eroded stapes suprastructure) and poor middle ear conditions, 
(45, 49)
 naturally have poorer outcomes, as compared to studies where a CWD 
technique was the only technique used, irrespective of middle ear conditions. (57, 
58, 61)
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In the latter group of studies, limited disease that allows for small cavity creation 
or medial canal wall reconstruction may have further enhanced audiological 
outcomes. In such cases, a more effective middle ear reconstruction is likely, with 
a more acoustically efficient transfer of vibrations to the inner ear.  
 
One exception to the above generalization however, was the findings of a study 
that dealt with extensive middle ear disease and a high percentage of patients with 
an absent stapes suprastructure. (63) The authors mentioned that their main 
indication for performing a CWD mastoidectomy is cholesteatoma with extensive 
middle ear involvement and stapes erosion. In such cases, they normally perform 
a two-stage procedure where they manage not only residual cholesteatoma pearls 
and adhesive otitis media, but also focus on hearing improvement by way of 
ossiculoplasty. They use silastic sheets in the middle ear at the first operation to 
maintain the middle ear space, and remove it at the second stage to allow for a 
TORP reconstruction. Even though hearing deterioration did occur post 
reconstruction, on average about 1dB per year, they reported exceptionally good 
results (ABG<20dB in 69% of cases). 
 
The audiological outcomes in the present study on CWD surgery was generally 
poor, more so in cases where the stapes suprastructure was absent. A possible 
reason for this lack of hearing improvement in cases presenting with an eroded 
suprastructure may be related to the tympanoplasty technique itself. Whenever a 
graft was placed in the middle ears of such cases, fascia was used to cover the 
entire promontory including the mobile footplate. Leaving the stapes footplate 
open or placing a STSG over it (as classically described), (28, 34) may have 
improved the outcomes achieved. 
 
The poor results achieved in cases with less severe disease and no stapes erosion 
however (see Table 8), is largely unexplained. In these cases, the possibility exists 
that middle ear aeration instead of being poor, was very good, and that the 
reconstructed tympanic membrane have lost contact with the stapes suprastructure 
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post healing. In such cases the more frequent use of a columella that slightly 
overestimates the distance between the stapes and the tympanic membrane, may 
have resulted in better outcomes. 
 
7.3.4 Variables 
Certain variables in the CWD mastoidectomy group of patients were studied to 
determine whether disease is more advanced in the local population, and whether 
it may have influenced the results achieved. 
 
7.3.4.1 Status of contra lateral ear 
Only two papers in the studied literature reported on the status of the opposite ear. 
Both of these showed a large percentage of patients presenting with uni-lateral 
disease (90%). (51, 57) The status of the contra lateral ear in this series of 
cholesteatoma showed that a large percentage of patients (38%) presented with 
bilateral COM, the majority of disease in the opposite ear also being CCOM. The 
reason for this finding is not clear, but suggests that the patients in this series 
experienced more morbidity and hearing disability from the disease compared to 
those in the literature. Hearing rehabilitation by way of middle ear reconstruction 
may thus be particularly beneficial in our population. 
 
7.3.4.2 Extent of disease 
Cholesteatoma extension to the mastoid region was encountered in 12 of 29 
patients, only 6/29 (20%) patients presenting with small attic cholesteatomas. 
Eighty percent of cholesteatoma thus were extensive and needed mastoidectomy 
for complete disease eradication. Literature from developed countries frequently 
report extensive cholesteatoma in less than 50% of cases. (47, 57, 61) 
 
The effect that this seemingly more extensive disease may have had on the 
outcome of surgery needs to be seen in the context of the predetermined goals of 
surgery. If the goal is to achieve a dry and safe ear, in this series, extent did not 
play a role in the outcome of surgery (p= 0, 63). In terms of morbidity reduction 
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(self cleansing ability and hearing improvement), although not formally studied, 
advanced disease may have played a role in outcomes as cavity sizes may have 
been bigger and middle ear conditions poorer.  
 
7.3.4.3 Status of stapes suprastructure 
As discussed the status of the stapes suprastructure per se does not give an 
indication of advance disease, but relates more to the type of cholesteatoma 
managed, viz. tensa- vs. attic cholesteatoma. (47) In the present series, this 
observation is also evident as the advanced disease seen in the pediatric age group 
was seldom associated with stapes erosion. In total, stapes erosion occurred in 
50% of assessable cases. The high percentage of patients where this structure was 
eroded or could not be assessed (secondary to severe middle ear disease) (60% of 
cases), is not only testament to the extensive middle ear disease frequently dealt 
with, but also explains in part the poor audiological outcomes achieved.  
 
In the literature, reported incidences of stapes erosion vary widely (between 20 
and 70 percent), most reporting erosion in around 30 % of cases. (45, 47, 50, 53, 61) No 
studies reported cases where the stapes could not be assessed though, possibly 
confirming the suspicion of a more extensive nature of disease dealt with in our 
setting. The effect that this variable may have had on audiological outcomes has 
been discussed. 
 
7.3.4.4 Age 
The age distribution of patients in this study reflects that in the literature, with a 
large percentage of patients (33%) falling in the pediatric age group, (53, 54, 57) the 
youngest of which was 6 years of age. The belief that pediatric patients present 
with more advanced and aggressive disease, are frequently mentioned in studies. 
The most popular opinion is that this observation may relate to the anatomic 
conditions present in these cases, rather than the cholesteatoma behaving 
differently as compared to adults. (48) 
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In this respect, it is interesting to note that none of the studied literature on 
pediatric cholesteatoma actually described their study populations to be of a more 
advanced nature than that reported by studies including all age groups. It may be 
that, although some cases of cholesteatoma in pediatric patients, especially the 
very young, do have relatively well-aerated mastoids and large cholesteatomas, 
older ones may not. In these older children, the percentage of sclerosed mastoids 
and limited cholesteatomas is likely to mirror that of adults. Unfortunately, none 
of the studied literature specifically looked into the possible relationship between 
age and advanced disease.  
 
In the present study, advanced disease was seen in the majority of pediatric 
patients. Ninety percent of patients had disease extending to at least the antrum, 
and 3/12 patients presented with a complication of cholesteatoma. Possible 
reasons for this discrepancy between our findings and that described in the 
literature, may be related to poor socio- economic conditions in the local 
population, where access to antibiotics may be limited and time to referral for 
specialist opinion are prolonged. These delays and lack of treatment may allow 
the cholesteatoma to spread deep into an expected well-aerated mastoid.  
 
Five out of thirteen (38%) pediatric cases had a small cavity technique performed 
with tympanic membrane reconstruction, and even though hearing improvement 
was negligible in all but one patient, hearing preservation was possible in all. In 
addition, a dry carefree cavity with an intact tympanic membrane was achieved in 
all five cases. 
Although literature reports indicate similarly high surgical success rates, a 
significant percentage of patients did experience worsening of their hearing (13-
30% of cases). (45, 47) A likely explanation for this finding lies in the differences in 
disease extent dealt with. Frequently in the removal of cholesteatoma, especially 
if limited, the ossicular chain may have been intact. The subsequent removal of 
the disease may require disruption and reconstruction of the ossicular chain, 
resulting in audiological outcomes that may be inferior to those present pre-
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operatively. The lack of additional hearing loss in the post-operative period in the 
present series is likely to be a result of a maximal conductive hearing loss that 
was present even before surgery. 
 
The finding of a dry ear in the eight cases subjected to an incomplete large cavity 
technique was largely unexpected. These patients, in the face of advanced disease 
and acutely infected mastoid and middle ears, had incomplete facial ridge removal 
in most cases, no tympanic membrane grafting and often a meatus smaller than 
the cavity created. 
The reason for these relatively good results is unclear. Local opinion is that 
because most cases of pediatric cholesteatoma may be of the pars flacida or attic 
type, (45) complete cholesteatoma removal may have been possible, as disease was 
either absent or limited in the middle ear. The resultant exteriorized mastoid 
cavity and possible neo-tympanic membrane formation (59) may have accounted 
for the high percentage of dry ears post-operatively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 80 
 
8. CONCLUSION 
 
This study was conducted in a retrospective way to determine the outcome of 
surgery for COM at our institution. It was done in view of a changed approach to 
certain important aspects of the surgery frequently performed at our institution.  
 
In terms of the study objectives set out in section 2 of this dissertation, we have 
found some important improvements in outcomes related to this changed 
approach, but have also identified areas where more improvements are needed. In 
addition, certain areas have been identified where an expansion of the indications 
of certain surgical techniques might improve outcomes further. 
 
We have found the BCIG technique effective for the majority of simple tympanic 
membrane perforations. The procedure resulted in graft success rates reflecting 
that reported in international literature, and produced sociable hearing (ACT< 
30dB) in all such patients. Hearing improvement, even in cases with large 
perforations, was not negatively affected by the thickness or rigidity of the graft. 
Rather it was found that the hearing improvement was directly related to the size 
of the perforation in that the larger the perforation the bigger the gain. 
 
Regarding the surgical technique itself, we found that the use of an endoscope 
allowed us to avoid external ear incisions in the majority of patients, improving 
patient comfort post-operatively and reducing theatre time. 
 
Unfortunately, a comparison with the more traditional FUG tympanoplasty was 
not possible as the patient numbers in the two study groups differed significantly. 
This was because the positive outcomes of the technique were of such 
significance that it became the choice method for the grafting of simple tympanic 
membrane perforations of any size and location at our institution. 
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In the Tympanomastoidectomy group of patients, we found the procedure to be 
inadequate in actively discharging ears presenting with a severe hearing loss.  
Graft success rates in patients with a limited hearing loss were significantly better 
than in this group of patients. Better patient selection and a more extensive 
exenteration of mastoid air cells may improve outcomes in future. 
 
The management of CCOM in our setting has changed as well as a move towards 
less destructive procedures was undertaken to reduce morbidity and theatre time. 
Regarding CWD surgery, the small cavity technique has proven to be relatively 
simple with a marked reduction in morbidity as compared to the large cavity 
technique. Although significant challenges remain regarding hearing outcomes 
achieved and follow up in future, the keeping and regular auditing of an otological 
database will go a long way in addressing these problems. The “feedback” that 
one gets from such a database will allow for ongoing improvement of surgical 
techniques. 
 
Important limitations of this study as a whole, included not only the fact that it 
was of a non-controlled nature, but also its small sample size and short follow up 
periods. In this respect, it is the author’s opinion that the establishment of a 
dedicated otology team and clinic will address these shortfalls in future, and 
clarify at least some of the controversies in the surgical management of COM.  
Future work regarding surgery itself should focus on, 
• the possible benefits that the BCIG technique might have on the outcome 
of staged ossiculoplasty in active NCCOM,  
• and whether an improvement in tympanoplasty techniques will materially 
affect audiological outcomes post small cavity CWD surgery. 
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10. APPENDIX 
 
TYMPANOPLASTY DATA TABLE 
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I 
1 14 F U S 33 F I IN 18 15 
2 46 F U S 65 F I IN 60 5 
3 40 M U M 35 C  I (RM) IN 20 15 
4 14 M - S 15 C I IN 10 5 
5 9 F - S 9 C I IN 8 1 
6 9 F U M 28 C I IN 18 10 
7 11 F B M 60 C I IN 60 0 
8 10 F U M 30 C I IN 20 10 
9 38 M U S 20 C I IN 20 0 
10 27 F U M 48 F III PORP IN 50 -2 
11 13 M U M 45 C I IN 25 20 
12 8 M U M 25 C I IN 20 5 
13 16 M U M 70 F III PORP P 75 -5 
14 8 M U M 25 C I IN 20 5 
15 12 M B L 45 F II CAR IN 10 35 
16 NA M U M 33 C I IN 16 17 
17 27 M U S 20 F I P 28 -8 
18 34 M U M 82 F I IN 82 0 
19 10 F B M 53 F I IN 30 23 
20 48 M U M 33 C I IN 20 13 
21 8 F U M 50 C I IN 16 34 
22 13 F B M 33 C I IN 17 16 
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F= Female, M= Male, U= Unilateral, B= Bilateral,- = Not Available ,S= Small perforation, M=Medium size perforation, 
L= Large perforation, NIL= No perforation, C= Cartilage Tympanic membrane reconstruction, F= Fascia underlay 
tympanic membrane reconstruction ,II= Type 2 Tympanoplasty, III= Type 3 Tympanoplasty PORP= Partial ossicular 
replacement prosthesis,, CAR= Cartilage Columella, RM= Redo Post Tympanomastoidectomy, RT= Redo Post 
Tympanoplasty, IN= Intact, P= Perforated, PTA= Pre operative Pure Tone average, PPTA= Post operative Pure Tone 
Average, HI= Hearing Improvement. 
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23 9 F B M 35 F I IN 15 20 
24 9 F B M 30 F I IN 10 20 
25 16 F U S 23 C I IN 10 13 
26 16 F B M 38 C II CAR IN 13 25 
27 46 F U M 50 C I IN 28 22 
28 10 M B M 47 C I IN 15 32 
29 44 F U S 25 C I IN -  
30 6 M U M 30 C I IN 17 13 
31 35 M U S 25 C I IN -  
32 10 F U M 35 C I IN 17 18 
33 32 M U M 53 C I IN 15 38 
34 35 F U S 45 C II CAR P -  
35 9 F U M 50 F III PORP - -  
36 14 F - - Na C I IN -  
37 22 F U NIL 50 F III CAR(RM) IN 50 0 
38 25 M U M 23 C I P 23 0 
39 27 F U M 20 F I(RT) P 26 -6 
40 27 F U S 26 C I IN 15 11 
41 11 F U S 23 C I IN 25 -2 
42 33 M U S 45 C I IN -  
43 10 M U M 20 C I IN 16 4 
44 15 M B M 20 C I IN 16 4 
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TYMPANOMASTOIDECTOMY DATA 
TABLE 
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TA
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I 
1 34 F U M D 45 C I IN D 30 15 
2 47 F U L Dc 67 F I IN D 28 39 
3 11 M U L Dc - F I P Dc - - 
4 16 F B M D 35 F III PORP IN D 18 17 
5 14 F B L Dc 50 F I P D 50 0 
6 50 F U Ad Dc 80 - MAST P Dc 80 0 
7 26 F U L Dc 40 F I IN D 30 10 
8 17 M U M Dc 40 F I IN D 21 19 
9 15 F B L D 35 F I IN D 10 25 
10 20 F U S Dc 48 F I IN D 28 20 
11 22 F U S Dc 65 - MAST P D 65 0 
12 44 M U M Dc 50 F I IN D 35 15 
13 12 M B L D 70 F I IN D 70 0 
14 12 M U Ad Dc 66 F I IN D 73 -7 
15 45 M B L Dc 66 F I P D 66 0 
16 39 F U M D 48 F I IN D 25 23 
17 62 M B M Dc 80 F I IN D 80 0 
18 48 F - L Dc 63 F I P D 63 0 
19 10 M - L Dc 55 F III CAR - - - - 
20 43 M B L Dc 80 - MAST P D 80 0 
21 35 F B L D 70 C III INC IN D 40 30 
22 50 F U L D 95 C I IN D 95 0 
23 39 M - - Dc 56 F I P Dc 56 0 
24 23 F B L D 70 F III CAR IN D 25 45 
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F= Female, M= Male, U= Unilateral, B= Bilateral,- = Not Available ,S= Small perforation, M=Medium size perforation, 
L= Large perforation, Ad= Adhesive otitis media, C= Cartilage Tympanic membrane reconstruction, F= Fascia underlay 
tympanic membrane reconstruction , III= Type 3 Tympanoplasty, MAST= Mastoidectomy only, INC= Incus Columella, 
CAR= Cartilage Columella,, IN= Intact, P= Perforated, Dc= Discharge present, D= Dry ear, PTA= Pre operative Pure 
Tone average, PPTA= Post operative Pure Tone Average, HI= Hearing Improvement. 
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25 68 F U S Dc 83  MAST P Dc 83 0 
26 41 F U L D 64 F I IN D 32 32 
27 9 F U M D 60 F III INC IN D 32 28 
28 48 F U L Dc 80  MAST P Dc 80 0 
29 47 F U M Dc 56 F I IN D 37 19 
30 54 M U S Dc -  MAST IN D - - 
31 36 M B M Dc 33 F I - - - - 
32 17 M B L Dc 53 F I P D - - 
33 37 M U M Dc 66 F I - - - - 
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CANAL WALL DOWN MASTOIDECTOMY 
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1 45 M B  Ant A 65 LC - P Dc crev rec 
small 
65  
2 42 F B  Na Na 50 LC - P Dc rec  53  
3 20 F B a Ant P 80 SC  III CLAS I Dry  80  
4 10 F U n Ant Na 46 LC - P Dry crev 43 E spa 
5 20 F B p At Na 55 LC - P Dc 57  
6 60 F B c At Na 70 LC - I Dry  60  
7 31 M Na Mast Na Na LC - P Dry small Na E spa 
8 6 F U n Na Na Na LC - P Dc crev rec 
small 
Na E spa 
9 19 M B c Ant A 60 LC - P Dry crev small 60  
10 20 M B c At A 65 LC - P Dry crev 83  
11 12 F B p Mast Na   43 LC  P Dry crev 45  
12 12 M Na Na A 65 LC - P Dry crev 75  
13 13 M U n Mast P 45 SC III INC I Dry 53  
14 39 F U n Na P 53 SC III CLAS I Dry 53  
15 14 F U n Mast P 55 SC III CLAS I Dc gran bowl 58  
16 12 F U n Mast Na 35 LC - P Dry 40  
17 45 F U n Mast P 70 SC III CAR I Dry 30  
18 47 F B c Mast P 43 SC III CAR I Dry 30  
19 47 F B c Mast A 50 SC IV I Dry 50  
20 43 F B a Mast A 80 SC IV I Dry 80  
21 10 M U n Mast P 43 SC III CLAS I Dry 43  
22 34 F U n Mast P 55 SC III CLAS P Dc gran bowl 55  
23 30 M U n Com P 60 SC III CLAS P Dc gran bowl 60  
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F= Femal, M= Male, Un= Unilateral, Bc= Bilateral Cholesteatoma opposite ear, Bp= Bilateral Perforation opposite ear, 
Na= Not Available, Ba= Bilateral Adhesive otitis media opposite ear, At= Attic, Ant= Antrum, Mast= Matoid, P= Present, 
A= Absent, LC= Large Cavity technique, SC= Small Cavity technique, III= Type 3 Tympanoplasty, CLAS= Classical, 
INC= Incus Collumella, CAR= Cartilage Columella, IV= Type 4 Tympanoplasty, IN= Intact, PE= Perforated, Dc= 
Discharge, gran= granulation tissue in mastoid bowl, crev= Crevices in mastoid cavity, E spa= Emergency procedure 
presenting with Sub periosteal Abcess, Small= Small meatus, PTA= Pre operative Pure Tone average, PPTA= Post 
operative Pure Tone Average. 
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24 18 M U n At P 40 SC III INC I Dry small 12  
25 20 M U n Mast A 80 SC IV I Dry 80 E spa 
26 50 M U n Com P 60 SC III CLAS P Dc gran small 60  
27 15 M U n At P 65 SC III CLAS I Dry 40  
28 18 M B c At A 52 SC IV I Dry 52  
29 15 F U n Ant P 28 SC III CLAS I Dry small 32  
30 20 F U n Ant A 65 LC - P Dc gran bowl 
rec 
65  
31 58 F U n Com P 63 SC III CAR I Dry  63  
32 8 F U n Ant Na 20 LC - P Dry Na  
33 15 M U n Ant Na Na LC - P Dry small Na E spa 
